BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, Rullier A, Cubel G, Couchy G, Imbeaud S. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740-748. [PMID: 17663417 DOI: 10.1002/hep.21743] [Cited by in Crossref: 421] [Cited by in F6Publishing: 343] [Article Influence: 28.1] [Reference Citation Analysis]
Number Citing Articles
1 Mitchell KA, Jain D. Diagnostic approach to needle biopsies of hepatic mass lesions. Diagnostic Histopathology 2008;14:598-608. [DOI: 10.1016/j.mpdhp.2008.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Vijay A, Elaffandi A, Khalaf H. Hepatocellular adenoma: An update. World J Hepatol 2015; 7(25): 2603-2609 [PMID: 26557953 DOI: 10.4254/wjh.v7.i25.2603] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
3 Bhoori S, Toffanin S, Sposito C, Germini A, Pellegrinelli A, Lampis A, Mazzaferro V. Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle. J Hepatol. 2010;52:771-775. [PMID: 20347502 DOI: 10.1016/j.jhep.2010.01.025] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 4.9] [Reference Citation Analysis]
4 Bellamy COC, Maxwell RS, Prost S, Azodo IA, Powell JJ, Manning JR. The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre: Hepatocellular adenomas. Histopathology 2013;62:431-45. [DOI: 10.1111/his.12011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
5 Shafaee Z, Liu S, Fiel MI, Blue R. Giant pedunculated hepatocellular adenoma masquerading as a subdiaphragmatic mass: Diagnostic challenges of a rare tumor. Radiol Case Rep 2021;16:84-9. [PMID: 33193934 DOI: 10.1016/j.radcr.2020.10.047] [Reference Citation Analysis]
6 Kotiyal S, Evason KJ. Exploring the Interplay of Telomerase Reverse Transcriptase and β-Catenin in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:4202. [PMID: 34439356 DOI: 10.3390/cancers13164202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kleiner DE. Histopathological Evaluation of Drug-Induced Liver Disease. Drug-Induced Liver Disease. Elsevier; 2013. pp. 241-63. [DOI: 10.1016/b978-0-12-387817-5.00015-7] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Abdel Wahab AHA, El-Halawany MS, Emam AA, Elfiky A, Abd Elmageed ZY. Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virus. Biomarkers 2017;22:621-8. [PMID: 27788588 DOI: 10.1080/1354750X.2016.1252966] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
9 Shih A, Lauwers GY, Balabaud C, Bioulac-Sage P, Misdraji J. Simultaneous occurrence of focal nodular hyperplasia and HNF1A-inactivated hepatocellular adenoma: a collision tumor simulating a composite FNH-HCA.Am J Surg Pathol. 2015;39:1296-1300. [PMID: 26274031 DOI: 10.1097/PAS.0000000000000477] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lin DC, Mayakonda A, Dinh HQ, Huang P, Lin L, Liu X, Ding LW, Wang J, Berman BP, Song EW, Yin D, Koeffler HP. Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma. Cancer Res. 2017;77:2255-2265. [PMID: 28302680 DOI: 10.1158/0008-5472.can-16-2822] [Cited by in Crossref: 91] [Cited by in F6Publishing: 57] [Article Influence: 18.2] [Reference Citation Analysis]
11 van Sprundel RG, van den Ingh TS, Desmet VJ, Katoonizadeh A, Penning LC, Rothuizen J, Roskams T, Spee B. Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours. Comp Hepatol. 2010;9:4. [PMID: 20167095 DOI: 10.1186/1476-5926-9-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
12 Cho SJ, Ferrell LD, Gill RM. Expression of liver fatty acid binding protein in hepatocellular carcinoma. Hum Pathol 2016;50:135-9. [PMID: 26997447 DOI: 10.1016/j.humpath.2015.12.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
13 Sheybani A, Gaba RC, Lokken RP, Berggruen SM, Mar WA. Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging. Curr Gastroenterol Rep 2017;19:58. [PMID: 29044439 DOI: 10.1007/s11894-017-0596-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
14 Klompenhouwer AJ, Ijzermans JNM. Malignant potential of hepatocellular adenoma. Liver Int 2017;37:966-7. [DOI: 10.1111/liv.13449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology. 2008;48:808-818. [PMID: 18688875 DOI: 10.1002/hep.22417] [Cited by in Crossref: 223] [Cited by in F6Publishing: 172] [Article Influence: 15.9] [Reference Citation Analysis]
16 Khemlina G, Ikeda S, Kurzrock R. The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. Mol Cancer. 2017;16:149. [PMID: 28854942 DOI: 10.1186/s12943-017-0712-x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 113] [Article Influence: 23.4] [Reference Citation Analysis]
17 Koehne de Gonzalez AK, Salomao MA, Lagana SM. Current concepts in the immunohistochemical evaluation of liver tumors. World J Hepatol 2015; 7(10): 1403-1411 [PMID: 26052385 DOI: 10.4254/wjh.v7.i10.1403] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
18 Verslype C, Van Cutsem E, Dicato M, Arber N, Berlin JD, Cunningham D, De Gramont A, Diaz-Rubio E, Ducreux M, Gruenberger T, Haller D, Haustermans K, Hoff P, Kerr D, Labianca R, Moore M, Nordlinger B, Ohtsu A, Rougier P, Scheithauer W, Schmoll HJ, Sobrero A, Tabernero J, van de Velde C. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Ann Oncol. 2009;20 Suppl 7:vii1-vii6. [PMID: 19497945 DOI: 10.1093/annonc/mdp281] [Cited by in Crossref: 54] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
19 Koch LK, Yeh MM. Nonalcoholic fatty liver disease (NAFLD): Diagnosis, pitfalls, and staging. Ann Diagn Pathol 2018;37:83-90. [PMID: 30312882 DOI: 10.1016/j.anndiagpath.2018.09.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
20 Zhou L, Pradhan-Sundd T, Poddar M, Singh S, Kikuchi A, Stolz DB, Shou W, Li Z, Nejak-Bowen KN, Monga SP. Mice with Hepatic Loss of the Desmosomal Protein γ-Catenin Are Prone to Cholestatic Injury and Chemical Carcinogenesis. Am J Pathol 2015;185:3274-89. [PMID: 26485505 DOI: 10.1016/j.ajpath.2015.08.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
21 Bioulac-Sage P, Sempoux C, Balabaud C. Immunohistochemical pitfalls in the diagnosis of focal nodular hyperplasia and inflammatory hepatocellular adenoma. Clin Res Hepatol Gastroenterol 2014;38:245-9. [PMID: 24525010 DOI: 10.1016/j.clinre.2014.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
22 Sakellariou S, Al-Hussaini H, Scalori A, Samyn M, Heaton N, Portmann B, Tobal K, Quaglia A. Hepatocellular adenoma in glycogen storage disorder type I: a clinicopathological and molecular study. Histopathology. 2012;60:E58-E65. [PMID: 22372484 DOI: 10.1111/j.1365-2559.2011.04153.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
23 Sugimoto K, Kondo F, Furuichi Y, Oshiro H, Nagao T, Saito K, Yoshida H, Imai Y, Fukusato T, Moriyasu F. Focal nodular hyperplasia-like lesion of the liver with focal adenoma features associated with idiopathic portal hypertension. Hepatol Res 2014;44:E309-15. [PMID: 24397430 DOI: 10.1111/hepr.12273] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
24 Kumagawa M, Matsumoto N, Watanabe Y, Hirayama M, Miura T, Nakagawara H, Ogawa M, Matsuoka S, Moriyama M, Takayama T, Sugitani M. Contrast-enhanced ultrasonographic findings of serum amyloid A-positive hepatocellular neoplasm: Does hepatocellular adenoma arise in cirrhotic liver? World J Hepatol 2016; 8(26): 1110-1115 [PMID: 27660679 DOI: 10.4254/wjh.v8.i26.1110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
25 Tateishi Y, Furuya M, Kondo F, Torii I, Nojiri K, Tanaka Y, Umeda S, Okudela K, Inayama Y, Endo I, Ohashi K. Hepatocyte nuclear factor-1 α inactivated hepatocellular adenomas in patient with congenital absence of the portal vein: a case report. Pathol Int 2013;63:358-63. [PMID: 23865574 DOI: 10.1111/pin.12072] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
26 Dokmak S, Cauchy F, Belghiti J. Resection, transplantation and local regional therapies for liver adenomas. Expert Rev Gastroenterol Hepatol 2014;8:803-10. [PMID: 24957321 DOI: 10.1586/17474124.2014.917957] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
27 Rebouissou S, Couchy G, Libbrecht L, Balabaud C, Imbeaud S, Auffray C, Roskams T, Bioulac-Sage P, Zucman-Rossi J. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol 2008;49:61-71. [PMID: 18466996 DOI: 10.1016/j.jhep.2008.03.013] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
28 Di Tommaso L, Roncalli M. Tissue Biomarkers in Hepatocellular Tumors: Which, When, and How. Front Med (Lausanne). 2017;4:10. [PMID: 28280721 DOI: 10.3389/fmed.2017.00010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
29 Tajiri K, Tsuneyama K, Kawai K, Atarashi Y, Minemura M, Sawada S, Tsukada K, Imura J, Sugiyama T. A case of progressing focal nodular hyperplasia and its molecular expression pattern. Clin J Gastroenterol 2014;7:271-7. [PMID: 26183749 DOI: 10.1007/s12328-014-0483-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
30 Fowler KJ, Brown JJ, Narra VR. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis. Hepatology. 2011;54:2227-2237. [PMID: 21932400 DOI: 10.1002/hep.24679] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 7.1] [Reference Citation Analysis]
31 Graham RP. Fibrolamellar Carcinoma: What Is New and Why It Matters. Surg Pathol Clin. 2018;11:377-387. [PMID: 29751881 DOI: 10.1016/j.path.2018.02.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
32 Guyader D, Latournerie M. [Incidental ultrasound finding of a 3 cm liver nodule in a 45-year-old woman taking hormonal substitution after hysterectomy performed for cervix carcinoma]. Gastroenterol Clin Biol 2009;33:F60-7. [PMID: 19766417 DOI: 10.1016/j.gcb.2009.08.006] [Reference Citation Analysis]
33 Pacheco MC, Monroe EJ, Horslen SP. Hepatic Adenoma Arising in a Patient With Alagille Syndrome: A Case Report. Pediatr Dev Pathol. 2018;21:585-589. [PMID: 29516774 DOI: 10.1177/1093526618762550] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
34 Blanc JF, Frulio N, Chiche L, Bioulac-Sage P, Balabaud C. Hepatocellular adenoma management: advances but still a long way to go. Hepat Oncol. 2015;2:171-180. [PMID: 30190996 DOI: 10.2217/hep.14.41] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 Cox AG, Hwang KL, Brown KK, Evason K, Beltz S, Tsomides A, O'Connor K, Galli GG, Yimlamai D, Chhangawala S, Yuan M, Lien EC, Wucherpfennig J, Nissim S, Minami A, Cohen DE, Camargo FD, Asara JM, Houvras Y, Stainier DYR, Goessling W. Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth. Nat Cell Biol 2016;18:886-96. [PMID: 27428308 DOI: 10.1038/ncb3389] [Cited by in Crossref: 95] [Cited by in F6Publishing: 92] [Article Influence: 15.8] [Reference Citation Analysis]
36 Kahn ME, French S, Wang HL. Hepatocellular Adenoma: Morphological and Molecular Variants and Distinction From Well-Differentiated Hepatocellular Carcinoma. Pathology Case Reviews 2009;14:13-20. [DOI: 10.1097/pcr.0b013e31819c4956] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
37 Zhao C, Pei S-, Cucchetti A, Tong T-, Ma Y-, Zhong J-, Li L-. Retracted: Systematic review: benefits and harms of transarterial embolisation for treating hepatocellular adenoma. Aliment Pharmacol Ther 2017;46:83-83. [DOI: 10.1111/apt.14044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
38 Salaria SN, Graham RP, Aishima S, Mounajjed T, Yeh MM, Torbenson MS. Primary hepatic tumors with myxoid change: morphologically unique hepatic adenomas and hepatocellular carcinomas. Am J Surg Pathol. 2015;39:318-324. [PMID: 25602798 DOI: 10.1097/pas.0000000000000382] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 2.9] [Reference Citation Analysis]
39 de'Angelis N, Memeo R, Calderaro J, Felli E, Salloum C, Compagnon P, Luciani A, Laurent A, Cherqui D, Azoulay D. Open and laparoscopic resection of hepatocellular adenoma: trends over 23 years at a specialist hepatobiliary unit. HPB (Oxford). 2014;16:783-788. [PMID: 24852081 DOI: 10.1111/hpb.12257] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
40 Grazioli L, Olivetti L, Mazza G, Bondioni MP. MR Imaging of Hepatocellular Adenomas and Differential Diagnosis Dilemma. Int J Hepatol 2013;2013:374170. [PMID: 23606972 DOI: 10.1155/2013/374170] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
41 Katabathina VS, Menias CO, Shanbhogue AK, Jagirdar J, Paspulati RM, Prasad SR. Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics. 2011;31:1529-1543. [PMID: 21997980 DOI: 10.1148/rg.316115527] [Cited by in Crossref: 106] [Cited by in F6Publishing: 77] [Article Influence: 10.6] [Reference Citation Analysis]
42 Roncalli M, Sciarra A, Tommaso LD. Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma. Clin Mol Hepatol 2016;22:199-211. [PMID: 27189732 DOI: 10.3350/cmh.2016.0101] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
43 Thoolen B, Ten Kate FJ, van Diest PJ, Malarkey DE, Elmore SA, Maronpot RR. Comparative histomorphological review of rat and human hepatocellular proliferative lesions. J Toxicol Pathol 2012;25:189-99. [PMID: 22988337 DOI: 10.1293/tox.25.189] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
44 Evason KJ, Grenert JP, Ferrell LD, Kakar S. Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas. Hum Pathol. 2013;44:750-758. [PMID: 23084586 DOI: 10.1016/j.humpath.2012.07.019] [Cited by in Crossref: 58] [Cited by in F6Publishing: 41] [Article Influence: 5.8] [Reference Citation Analysis]
45 Huang W, Tsai J, Jeng Y. Complementary roles of β-catenin and glutamine synthetase immunostaining in diagnosis of chemotherapy-treated and untreated hepatoblastoma. Journal of the Formosan Medical Association 2017;116:549-53. [DOI: 10.1016/j.jfma.2016.09.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
46 Yeh Y, Lei H, Chen M, Ho H, Chiu L, Li C, Wang Y. C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis. American Journal of Surgical Pathology 2017;41:1630-41. [DOI: 10.1097/pas.0000000000000957] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
47 Sempoux C, Balabaud C, Bioulac-Sage P. Malignant transformation of hepatocellular adenoma. Hepat Oncol. 2014;1:421-431. [PMID: 30190977 DOI: 10.2217/hep.14.14] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
48 Fonseca S, Hoton D, Dardenne S, Annet L, Hubert C, Godecharles S, Jouret-Mourin A, Reding R, Otte JB, Rahier J, Gigot JF, Sempoux C. Histological and immunohistochemical revision of hepatocellular adenomas: a learning experience. Int J Hepatol 2013;2013:398308. [PMID: 23533787 DOI: 10.1155/2013/398308] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
49 Piotti KC, Yantiss RK, Chen Z, Jessurun J. Serum amyloid A immunohistochemical staining patterns in hepatitis. Histopathology. 2016;69:937-942. [PMID: 27302660 DOI: 10.1111/his.13016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
50 Shyu S, Ali SZ. Significance of hepatocyte atypia in liver fine needle aspiration. Diagn Cytopathol 2021. [PMID: 34459153 DOI: 10.1002/dc.24851] [Reference Citation Analysis]
51 Sempoux C, Balabaud C, Bioulac-Sage P. Pictures of focal nodular hyperplasia and hepatocellular adenomas. World J Hepatol 2014; 6(8): 580-595 [PMID: 25232451 DOI: 10.4254/wjh.v6.i8.580] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
52 Liau SS, Qureshi MS, Praseedom R, Huguet E. Molecular pathogenesis of hepatic adenomas and its implications for surgical management. J Gastrointest Surg. 2013;17:1869-1882. [PMID: 23835731 DOI: 10.1007/s11605-013-2274-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
53 Shao N, Pandey A, Ghasabeh MA, Khoshpouri P, Pandey P, Varzaneh FN, Zarghampour M, Fouladi D, Pawlik TM, Anders RA, Kamel IR. Long-term follow-up of hepatic adenoma and adenomatosis: analysis of size change on imaging with histopathological correlation. Clin Radiol 2018;73:958-65. [PMID: 30031588 DOI: 10.1016/j.crad.2018.06.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
54 Mounajjed T. Hepatocellular Adenoma and Focal Nodular Hyperplasia. Clin Liver Dis (Hoboken) 2021;17:244-8. [PMID: 33968383 DOI: 10.1002/cld.1069] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Storey SM, McIntosh AL, Huang H, Landrock KK, Martin GG, Landrock D, Payne HR, Atshaves BP, Kier AB, Schroeder F. Intracellular cholesterol-binding proteins enhance HDL-mediated cholesterol uptake in cultured primary mouse hepatocytes. Am J Physiol Gastrointest Liver Physiol 2012;302:G824-39. [PMID: 22241858 DOI: 10.1152/ajpgi.00195.2011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
56 De Vito C, Papathomas G T, Pedica F, Kane P, Amir A, Heaton N, Quaglia A. Synchronous Unicentric Castleman Disease and Inflammatory Hepatocellular Adenoma: a Case Report. Ann Hepatol 2019;18:263-8. [PMID: 31113603 DOI: 10.5604/01.3001.0012.7936] [Reference Citation Analysis]
57 Purysko AS, Remer EM, Coppa CP, Obuchowski NA, Schneider E, Veniero JC. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI. AJR Am J Roentgenol. 2012;198:115-123. [PMID: 22194486 DOI: 10.2214/ajr.11.6836] [Cited by in Crossref: 65] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
58 Torbenson M, Washington K. Pathology of liver disease: advances in the last 50 years. Hum Pathol 2020;95:78-98. [PMID: 31493428 DOI: 10.1016/j.humpath.2019.08.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
59 Tsai JH, Jeng YM, Pan CC, Lu SW, Kuo YJ. Immunostaining of glutamine synthetase is a sensitive and specific marker for diagnosing focal nodular hyperplasia in needle biopsy. Pathology 2012;44:605-10. [PMID: 22990279 DOI: 10.1097/PAT.0b013e32835817c6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
60 Lachenmayer A, Alsinet C, Savic R, Cabellos L, Toffanin S, Hoshida Y, Villanueva A, Minguez B, Newell P, Tsai HW. Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. Clin Cancer Res. 2012;18:4997-5007. [PMID: 22811581 DOI: 10.1158/1078-0432.ccr-11-2322] [Cited by in Crossref: 163] [Cited by in F6Publishing: 101] [Article Influence: 16.3] [Reference Citation Analysis]
61 Lagana SM, Salomao M, Bao F, Moreira RK, Lefkowitch JH, Remotti HE. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma. Appl Immunohistochem Mol Morphol. 2013;21:170-176. [PMID: 22914605 DOI: 10.1097/pai.0b013e31825d527f] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
62 Mounajjed T, Yasir S, Aleff PA, Torbenson MS. Pigmented hepatocellular adenomas have a high risk of atypia and malignancy. Mod Pathol 2015;28:1265-74. [PMID: 26205181 DOI: 10.1038/modpathol.2015.83] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
63 Hale G, Liu X, Hu J, Xu Z, Che L, Solomon D, Tsokos C, Shafizadeh N, Chen X, Gill R, Kakar S. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma. Mod Pathol 2016;29:1370-80. [PMID: 27469330 DOI: 10.1038/modpathol.2016.122] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
64 Miller GC, Campbell CM, Manoharan B, Bryant R, Cavallucci D, O'Rourke N, Clouston AD. Subclassification of hepatocellular adenomas: practical considerations in the implementation of the Bordeaux criteria. Pathology 2018;50:593-9. [PMID: 30149989 DOI: 10.1016/j.pathol.2018.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
65 Chálim Rebelo C, Moura DB, Flor de Lima M, Dutra E, Amaral R, Pereira JR, Duarte MA. An Extreme Case of Liver Adenomatosis: Are They All the Same? Gastroenterology Insights 2022;13:68-76. [DOI: 10.3390/gastroent13010008] [Reference Citation Analysis]
66 Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 2008;48:163-170. [PMID: 17997499 DOI: 10.1016/j.jhep.2007.10.003] [Cited by in Crossref: 166] [Cited by in F6Publishing: 124] [Article Influence: 11.1] [Reference Citation Analysis]
67 Bedossa P, Paradis V, Zucman-rossi J. Cellular and Molecular Techniques. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 88-110. [DOI: 10.1016/b978-0-7020-6697-9.00002-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Chu HH, Moon WS. β-catenin activated hepatocellular adenoma. Clin Mol Hepatol 2013;19:185-9. [PMID: 23837144 DOI: 10.3350/cmh.2013.19.2.185] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
69 Huang WC, Liau JY, Jeng YM, Liu KL, Lin CN, Song HL, Tsai JH. Hepatocellular adenoma in Taiwan: Distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype. J Gastroenterol Hepatol 2020;35:680-8. [PMID: 31698521 DOI: 10.1111/jgh.14903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
70 Pelletier L, Rebouissou S, Vignjevic D, Bioulac-Sage P, Zucman-Rossi J. HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines. BMC Cancer 2011;11:427. [PMID: 21975049 DOI: 10.1186/1471-2407-11-427] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
71 Zheng Z, Sze CW, Keng CT, Al-Haddawi M, Liu M, Tan SY, Kwek HL, Her Z, Chan XY, Barnwal B, Loh E, Chang KTE, Tan TC, Tan YJ, Chen Q. Hepatitis C virus mediated chronic inflammation and tumorigenesis in the humanised immune system and liver mouse model. PLoS One 2017;12:e0184127. [PMID: 28886065 DOI: 10.1371/journal.pone.0184127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
72 Lefkowitch JH. Hepatobiliary pathology. Curr Opin Gastroenterol 2008;24:269-77. [PMID: 18408454 DOI: 10.1097/MOG.0b013e3282f8e28f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
73 Smoot RL, Nagorney DM, Chandan VS, Que FG, Schleck CD, Harmsen WS, Kendrick ML. Resection of hepatocellular carcinoma in patients without cirrhosis. Br J Surg. 2011;98:697-703. [PMID: 21280030 DOI: 10.1002/bjs.7401] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
74 Buell JF, Cherqui D, Geller DA, O'Rourke N, Iannitti D, Dagher I, Koffron AJ, Thomas M, Gayet B, Han HS, Wakabayashi G, Belli G, Kaneko H, Ker CG, Scatton O, Laurent A, Abdalla EK, Chaudhury P, Dutson E, Gamblin C, D'Angelica M, Nagorney D, Testa G, Labow D, Manas D, Poon RT, Nelson H, Martin R, Clary B, Pinson WC, Martinie J, Vauthey JN, Goldstein R, Roayaie S, Barlet D, Espat J, Abecassis M, Rees M, Fong Y, McMasters KM, Broelsch C, Busuttil R, Belghiti J, Strasberg S, Chari RS; World Consensus Conference on Laparoscopic Surgery. The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg 2009;250:825-30. [PMID: 19916210 DOI: 10.1097/sla.0b013e3181b3b2d8] [Cited by in Crossref: 969] [Cited by in F6Publishing: 375] [Article Influence: 74.5] [Reference Citation Analysis]
75 Sempoux C, Chang C, Gouw A, Chiche L, Zucman-Rossi J, Balabaud C, Bioulac-Sage P. Benign hepatocellular nodules: what have we learned using the patho-molecular classification. Clin Res Hepatol Gastroenterol. 2013;37:322-327. [PMID: 23876350 DOI: 10.1016/j.clinre.2013.04.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
76 Solbach P, Potthoff A, Raatschen HJ, Soudah B, Lehmann U, Schneider A, Gebel MJ, Manns MP, Vogel A. Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report. BMC Gastroenterol 2015;15:60. [PMID: 25986067 DOI: 10.1186/s12876-015-0288-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
77 Canal F, Anthony E, Lescure A, Del Nery E, Camonis J, Perez F, Ragazzon B, Perret C. A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1. BMC Cancer 2015;15:1020. [PMID: 26715116 DOI: 10.1186/s12885-015-2037-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
78 Ilboudo A, Nault JC, Dubois-Pot-Schneider H, Corlu A, Zucman-Rossi J, Samson M, Le Seyec J. Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma. BMC Cancer. 2014;14:7. [PMID: 24393405 DOI: 10.1186/1471-2407-14-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
79 Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford). 2010;12:509-522. [PMID: 20887318 DOI: 10.1111/j.1477-2574.2010.00222.x] [Cited by in Crossref: 212] [Cited by in F6Publishing: 183] [Article Influence: 19.3] [Reference Citation Analysis]
80 Grieser C, Steffen IG, Kramme IB, Bläker H, Kilic E, Perez Fernandez CM, Seehofer D, Schott E, Hamm B, Denecke T. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Eur Radiol 2014;24:1339-48. [PMID: 24658870 DOI: 10.1007/s00330-014-3144-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
81 van Sprundel RG, van den Ingh TS, Schotanus BA, van Wolferen ME, Penning LC, Rothuizen J, Spee B. Cellular characteristics of keratin 19-positive canine hepatocellular tumours explain its aggressive behaviour. Vet Rec Open 2017;4:e000212. [PMID: 29118993 DOI: 10.1136/vetreco-2016-000212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
82 Bioulac-Sage P, Taouji S, Possenti L, Balabaud C. Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver Int. 2012;32:1217-1221. [PMID: 22429502 DOI: 10.1111/j.1478-3231.2012.02786.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 71] [Article Influence: 8.6] [Reference Citation Analysis]
83 Nault JC, Blanc JF, Moga L, Calderaro J, Dao T, Guiu B, Hocquelet A, Paradis V, Salamé E, de Lédinghen V, Bourlière M, Bureau C, Ganne-Carrié N. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF BENIGN LIVER TUMOURS. Clin Res Hepatol Gastroenterol 2021;:101765. [PMID: 34333196 DOI: 10.1016/j.clinre.2021.101765] [Reference Citation Analysis]
84 Stueck AE, Wanless IR. Hepatocyte buds derived from progenitor cells repopulate regions of parenchymal extinction in human cirrhosis. Hepatology. 2015;61:1696-1707. [PMID: 25644399 DOI: 10.1002/hep.27706] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 9.4] [Reference Citation Analysis]
85 Ronot M, Paradis V, Duran R, Kerbaol A, Vullierme MP, Belghiti J, Valla DC, Vilgrain V. MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours. Eur Radiol. 2013;23:914-923. [PMID: 23064717 DOI: 10.1007/s00330-012-2676-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
86 Toiyama Y, Inoue Y, Yasuda H, Yoshiyama S, Araki T, Miki C, Kusunoki M. Hepatocellular adenoma containing hepatocellular carcinoma in a male patient with familial adenomatous polyposis coli: Report of a case. Surg Today 2011;41:1442-6. [PMID: 21922375 DOI: 10.1007/s00595-010-4451-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
87 Takayassu TC, Marchiori E, Eiras A, Cabral RF, Cabral FC, Batista RR, Zanetti G, Dias PC. Telangiectatic adenoma - computed tomography and magnetic resonance findings: a case report and review of the literature. Cases J 2009;2:24. [PMID: 19128493 DOI: 10.1186/1757-1626-2-24] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
88 You J, Yang H, Lai Y, Simon L, Au J, Burkart AL. ARID2, p110α, p53, and β-catenin protein expression in hepatocellular carcinoma and clinicopathologic implications. Hum Pathol 2015;46:1068-77. [PMID: 26284269 DOI: 10.1016/j.humpath.2015.05.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
89 Bellizzi AM. Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms. Seminars in Diagnostic Pathology 2013;30:329-61. [DOI: 10.1053/j.semdp.2013.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
90 Sousa CMN, Gadelha PMM, Cartaxo RS, Pedrosa GWH, Honorio RS, Lima JMC, Coelho GR, Coelho CR. Hepatocyte Nuclear Factor 1α-Mutated Hepatocellular Adenomas: An Atypical Presentation. Case Rep Gastroenterol 2017;11:637-42. [PMID: 29282384 DOI: 10.1159/000480376] [Reference Citation Analysis]
91 Agrawal S, Agarwal S, Arnason T, Saini S, Belghiti J. Management of Hepatocellular Adenoma: Recent Advances. Clin Gastroenterol Hepatol. 2015;13:1221-1230. [PMID: 24909909 DOI: 10.1016/j.cgh.2014.05.023] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
92 Shanbhogue AK, Prasad SR, Takahashi N, Vikram R, Sahani DV. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: Implications for imaging and management. Radiology. 2011;258:673-693. [PMID: 21339346 DOI: 10.1148/radiol.10100376] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
93 Dokmak S, Belghiti J. Will weight loss become a future treatment of hepatocellular adenoma in obese patients? Liver Int. 2015;35:2228-2232. [PMID: 26216699 DOI: 10.1111/liv.12925] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
94 Chandan VS, Shah SS, Mounajjed T, Torbenson MS, Wu T. Copper deposition in focal nodular hyperplasia and inflammatory hepatocellular adenoma. J Clin Pathol 2018;71:504-7. [DOI: 10.1136/jclinpath-2017-204820] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
95 Berry RS, Gullapalli RR, Wu J, Morris K, Hanson JA. Diffuse glutamine synthetase overexpression restricted to areas of peliosis in a β-catenin-activated hepatocellular adenoma: a potential pitfall in glutamine synthetase interpretation. Virchows Arch 2014;465:241-5. [PMID: 24997695 DOI: 10.1007/s00428-014-1620-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
96 Zech CJ, Bartolozzi C, Bioulac-sage P, Chow PK, Forner A, Grazioli L, Huppertz A, Laumonier H, Min Lee J, Murakami T, Ricke J, Sirlin CB. Consensus Report of the Fifth International Forum for Liver MRI. American Journal of Roentgenology 2013;201:97-107. [DOI: 10.2214/ajr.12.9491] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
97 Sannier A, Cazejust J, Lequoy M, Cervera P, Scatton O, Rosmorduc O, Wendum D. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia. Liver Int 2016;36:1668-76. [PMID: 26969817 DOI: 10.1111/liv.13113] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
98 Paradis V. Benign Liver Tumors: An update. Clinics in Liver Disease 2010;14:719-29. [DOI: 10.1016/j.cld.2010.07.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
99 Thoolen B, Ten Kate FJW, Castigliego D, van Diest PJ, Malarkey DE, Elmore SA, Maronpot RR. Comparative immunohistochemical investigation of rat and human hepatocellular carcinomas. Journal of Histotechnology 2013;36:75-85. [DOI: 10.1179/2046023613y.0000000026] [Reference Citation Analysis]
100 Pilati C, Letouzé E, Nault JC, Imbeaud S, Boulai A, Calderaro J, Poussin K, Franconi A, Couchy G, Morcrette G. Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation. Cancer Cell. 2014;25:428-441. [PMID: 24735922 DOI: 10.1016/j.ccr.2014.03.005] [Cited by in Crossref: 178] [Cited by in F6Publishing: 147] [Article Influence: 22.3] [Reference Citation Analysis]
101 Dardenne S, Hubert C, Sempoux C, Annet L, Jouret-Mourin A, Horsmans Y, Van Beers BE, Zech F, Gigot JF. Conservative and operative management of benign solid hepatic tumours: a successful stratified algorithm. Eur J Gastroenterol Hepatol. 2010;22:1337-1344. [PMID: 20683192 DOI: 10.1097/MEG.0b013e32833db907] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
102 Sala M, Gonzales D, Leste-Lasserre T, Dugot-Senant N, Paradis V, Di Tommaso S, Dupuy JW, Pitard V, Dourthe C, Sciarra A, Sempoux C, Ferrell LD, Clouston AD, Miller G, Yeh MM, Thung S, Gouw ASH, Quaglia A, Han J, Huan J, Fan C, Crawford J, Nakanuma Y, Harada K, le Bail B, Castain C, Frulio N, Trillaud H, Possenti L, Blanc JF, Chiche L, Laurent C, Balabaud C, Bioulac-Sage P, Raymond AA, Saltel F. ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice. Hepatol Commun 2020;4:809-24. [PMID: 32490318 DOI: 10.1002/hep4.1514] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
103 Shafizadeh N, Genrich G, Ferrell L, Kakar S. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up. Human Pathology 2014;45:976-83. [DOI: 10.1016/j.humpath.2013.12.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
104 Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Will the pathomolecular classification of hepatocellular adenomas improve their clinical management? J Hepatol. 2011;55:8-10. [PMID: 21300118 DOI: 10.1016/j.jhep.2011.01.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
105 Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun 2013;4:2218. [PMID: 23887712 DOI: 10.1038/ncomms3218] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Mironov O, Jaberi A, Beecroft R, Kachura JR. Retrospective Single-Arm Cohort Study of Patients with Hepatocellular Adenomas Treated with Percutaneous Thermal Ablation. Cardiovasc Intervent Radiol 2018;41:935-41. [DOI: 10.1007/s00270-018-1893-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
107 Spannbauer MM, Trautwein C, Kowdley K, Mccaughan G, Trautwein C. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumors. Hepatology 2009;49:1387-9. [DOI: 10.1002/hep.22902] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
108 Baranes L, Chiaradia M, Pigneur F, Decaens T, Djabbari M, Zegaï B, Costentin C, Laurent A, Calderaro J, Rahmouni A. Imaging benign hepatocellular tumors: atypical forms and diagnostic traps. Diagn Interv Imaging. 2013;94:677-695. [PMID: 23830777 DOI: 10.1016/j.diii.2013.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
109 Bioulac-sage P, Balabaud C, Zucman-rossi J. Les tumeurs hépatocytaires bénignes – des connaissances récentes : de la biologie moléculaire au diagnostic. Gastroentérologie Clinique et Biologique 2008;32:296-303. [DOI: 10.1016/j.gcb.2008.02.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
110 Bioulac-Sage P, Laumonier H, Cubel G, Saric J, Balabaud C. Over-expression of glutamine synthase in focal nodular hyperplasia (part 1): early stages in the formation support the hypothesis of a focal hyper-arterialisation with venous (portal and hepatic) and biliary damage. Comp Hepatol 2008;7:2. [PMID: 18312631 DOI: 10.1186/1476-5926-7-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
111 Han HS, Yoon YS, Cho JY, Hwang DW. Laparoscopic liver resection for hepatocellular carcinoma: korean experiences. Liver Cancer 2013;2:25-30. [PMID: 24159593 DOI: 10.1159/000346224] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
112 Gregory J, Paisant A, Paulatto L, Raynaud L, Bertin C, Kerbaol A, Vullierme MP, Paradis V, Vilgrain V, Ronot M. Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas. Eur J Radiol 2020;128:109027. [PMID: 32361381 DOI: 10.1016/j.ejrad.2020.109027] [Reference Citation Analysis]
113 Laumonier H, Frulio N, Laurent C, Balabaud C, Zucman-Rossi J, Bioulac-Sage P. Focal nodular hyperplasia with major sinusoidal dilatation: a misleading entity. BMJ Case Rep 2010;2010:bcr0920103311. [PMID: 22798311 DOI: 10.1136/bcr.09.2010.3311] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
114 Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, Laurent C, Blanc JF, Cubel G, Trillaud H, Zucman-Rossi J, Balabaud C, Saric J. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009;50:481-9. [PMID: 19585623 DOI: 10.1002/hep.22995] [Cited by in Crossref: 317] [Cited by in F6Publishing: 233] [Article Influence: 24.4] [Reference Citation Analysis]
115 Trevisani F, Frigerio M, Santi V, Grignaschi A, Bernardi M. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis. 2010;42:341-347. [PMID: 19828388 DOI: 10.1016/j.dld.2009.09.002] [Cited by in Crossref: 100] [Cited by in F6Publishing: 93] [Article Influence: 7.7] [Reference Citation Analysis]
116 Nakashima T, Takayama Y, Nishie A, Asayama Y, Baba S, Yamashita Y, Shirabe K, Kubo Y, Hida T, Honda H. Hepatocellular adenoma showing high uptake of (18)F-fluorodeoxyglucose (FDG) via an increased expression of glucose transporter 2 (GLUT-2). Clin Imaging. 2014;38:888-891. [PMID: 25034402 DOI: 10.1016/j.clinimag.2014.06.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
117 Pelletier L, Rebouissou S, Paris A, Rathahao-paris E, Perdu E, Bioulac-sage P, Imbeaud S, Zucman-rossi J. Loss of hepatocyte nuclear factor 1α function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis. Hepatology 2010;51:557-66. [DOI: 10.1002/hep.23362] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
118 Kakar S, Evason KJ, Ferrell LD. Well-differentiated hepatocellular neoplasm of uncertain malignant potential: proposal for a new diagnostic category—reply. Human Pathology 2014;45:660-1. [DOI: 10.1016/j.humpath.2013.09.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
119 Tse JR, Naini BV, Lu DS, Raman SS. Qualitative and Quantitative Gadoxetic Acid-enhanced MR Imaging Helps Subtype Hepatocellular Adenomas. Radiology 2016;279:118-27. [PMID: 26505921 DOI: 10.1148/radiol.2015142449] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
120 Bioulac-Sage P, Laumonier H, Laurent C, Zucman-Rossi J, Balabaud C. Hepatocellular adenoma: what is new in 2008. Hepatol Int. 2008;2:316-321. [PMID: 19669260 DOI: 10.1007/s12072-008-9075-0] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
121 Yee EU, Hale G, Liu X, Lin DI. Hepatocellular Adenoma of the Placenta With Updated Immunohistochemical and Molecular Markers: A Case Report. Int J Surg Pathol 2016;24:640-3. [DOI: 10.1177/1066896916645186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
122 Desmet VJ. East-West pathology agreement on precancerous liver lesions and early hepatocellular carcinoma. Hepatology. 2009;49:355-357. [PMID: 19127518 DOI: 10.1002/hep.22681] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
123 Balabaud C, Laurent C, Frulio N, Marie Christine SP, Le Bail B, Possenti L, Blanc JF, Chiche L, Bioulac-sage P. Repeat surgery in HNF1alpha-inactivated adenomatosis. Clinics and Research in Hepatology and Gastroenterology 2019;43:460-7. [DOI: 10.1016/j.clinre.2018.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
124 Desjonqueres E, Campani C, Marra F, Zucman-Rossi J, Nault JC. Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice. Liver Int 2022. [PMID: 34982503 DOI: 10.1111/liv.15152] [Reference Citation Analysis]
125 Srirattanapong S, Angthong W, Kim BS, Hayashi PH, Gerber DA, Woosley JT, Peacock J, Ranatunga A, Semelka RC. Liver adenomatosis: serial investigation on MRI. Abdom Imaging 2014;39:269-82. [PMID: 24375021 DOI: 10.1007/s00261-013-0056-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
126 Henriet E, Abou Hammoud A, Dupuy J, Dartigues B, Ezzoukry Z, Dugot-senant N, Leste-lasserre T, Pallares-lupon N, Nikolski M, Le Bail B, Blanc J, Balabaud C, Bioulac-sage P, Raymond A, Saltel F. Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk: Henriet, Abou Hammoud, et al. Hepatology 2017;66:2016-28. [DOI: 10.1002/hep.29336] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 9.6] [Reference Citation Analysis]
127 Nguyen TB, Roncalli M, Di Tommaso L, Kakar S. Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma. Mod Pathol. 2016;29:283-292. [PMID: 26769138 DOI: 10.1038/modpathol.2015.162] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
128 Ronot M, Bahrami S, Calderaro J, Valla DC, Bedossa P, Belghiti J, Vilgrain V, Paradis V. Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology. 2011;53:1182-1191. [PMID: 21480324 DOI: 10.1002/hep.24147] [Cited by in Crossref: 148] [Cited by in F6Publishing: 124] [Article Influence: 13.5] [Reference Citation Analysis]
129 Sergi CM. Carcinoma of the Liver in Children and Adolescents. In: Sergi CM, editor. Liver Cancer. Exon Publications; 2021. pp. 1-38. [DOI: 10.36255/exonpublications.livercancer.2021.ch1] [Reference Citation Analysis]
130 Kleiner DE. Liver Injury Due to Drugs and Herbal Agents. Practical Hepatic Pathology: a Diagnostic Approach. Elsevier; 2018. pp. 327-70. [DOI: 10.1016/b978-0-323-42873-6.00023-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
131 Rebouissou S, Franconi A, Calderaro J, Letouzé E, Imbeaud S, Pilati C, Nault J, Couchy G, Laurent A, Balabaud C, Bioulac‐sage P, Zucman‐rossi J. Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression. Hepatology 2016;64:2047-61. [DOI: 10.1002/hep.28638] [Cited by in Crossref: 127] [Cited by in F6Publishing: 123] [Article Influence: 21.2] [Reference Citation Analysis]
132 Marginean EC, Gown AM, Jain D. Diagnostic Approach to Hepatic Mass Lesions and Role of Immunohistochemistry. Surgical Pathology Clinics 2013;6:333-65. [DOI: 10.1016/j.path.2013.03.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
133 Ferrell LD, Kakar S, Terracciano LM, Wee A. Tumours and Tumour-like Lesions of the Liver. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 780-879. [DOI: 10.1016/b978-0-7020-6697-9.00013-3] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
134 Lin YY, Yu MW, Lin SM, Lee SD, Chen CL, Chen DS, Chen PJ. Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma. Cancer 2017;123:3966-76. [PMID: 28662289 DOI: 10.1002/cncr.30851] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
135 Kim GJ, Seok JY, Rhee H, Choi JY, Choi JS, Kim KS, Thung S, Park YN. β-Catenin activated hepatocellular adenoma: a report of three cases in Korea. Gut Liver 2014;8:452-8. [PMID: 25071913 DOI: 10.5009/gnl.2014.8.4.452] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
136 Shafizadeh N, Kakar S. Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques. Adv Anat Pathol. 2011;18:438-445. [PMID: 21993269 DOI: 10.1097/pap.0b013e318234abb4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 7] [Article Influence: 5.7] [Reference Citation Analysis]
137 Bioulac-Sage P, Blanc JF, Rebouissou S, Balabaud C, Zucman-Rossi J. Genotype phenotype classification of hepatocellular adenoma. World J Gastroenterol 2007; 13(19): 2649-2654 [PMID: 17569132 DOI: 10.3748/wjg.v13.i19.2649] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
138 Choi WT, Ramachandran R, Kakar S. Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens. Hum Pathol. 2017;63:1-13. [PMID: 28087475 DOI: 10.1016/j.humpath.2016.12.025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
139 Malle E, Sodin-Semrl S, Kovacevic A. Serum amyloid A: an acute-phase protein involved in tumour pathogenesis. Cell Mol Life Sci 2009;66:9-26. [PMID: 18726069 DOI: 10.1007/s00018-008-8321-x] [Cited by in Crossref: 122] [Cited by in F6Publishing: 122] [Article Influence: 9.4] [Reference Citation Analysis]
140 Taouli B. Diffusion-weighted MR Imaging for Liver Lesion Characterization: A Critical Look. Radiology 2012;262:378-80. [DOI: 10.1148/radiol.11112417] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 5.2] [Reference Citation Analysis]
141 Fleming KE, Wanless IR. Glutamine synthetase expression in activated hepatocyte progenitor cells and loss of hepatocellular expression in congestion and cirrhosis. Liver Int. 2013;33:525-534. [PMID: 23362937 DOI: 10.1111/liv.12099] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
142 Li H, Rong Z, Wang H, Zhang N, Pu C, Zhao Y, Zheng X, Lei C, Liu Y, Luo X, Chen J, Wang F, Wang A, Wang J. Proteomic analysis revealed common, unique and systemic signatures in gender-dependent hepatocarcinogenesis. Biol Sex Differ 2020;11:46. [PMID: 32792008 DOI: 10.1186/s13293-020-00316-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
143 Clément B, Chêne G, Degos F. A national collection of liver tumours: Lessons learnt from 6 years of biobanking in France. Cancer Letters 2009;286:140-4. [DOI: 10.1016/j.canlet.2009.04.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
144 Bioulac-Sage P, Laumonier H, Cubel G, Rossi JZ, Balabaud C. Hepatic resection for inflammatory hepatocellular adenomas: pathological identification of micronodules expressing inflammatory proteins. Liver Int. 2010;30:149-154. [PMID: 19845852 DOI: 10.1111/j.1478-3231.2009.02098.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
145 Sasaki M, Nakanuma Y. Overview of hepatocellular adenoma in Japan. Int J Hepatol 2012;2012:648131. [PMID: 22973519 DOI: 10.1155/2012/648131] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
146 Sasaki M, Yoneda N, Kitamura S, Sato Y, Nakanuma Y. A serum amyloid A-positive hepatocellular neoplasm arising in alcoholic cirrhosis: a previously unrecognized type of inflammatory hepatocellular tumor. Mod Pathol. 2012;25:1584-1593. [PMID: 22766792 DOI: 10.1038/modpathol.2012.114] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
147 Cho SW, Marsh JW, Steel J, Holloway SE, Heckman JT, Ochoa ER, Geller DA, Gamblin TC. Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol. 2008;15:2795-2803. [PMID: 18696154 DOI: 10.1245/s10434-008-0090-0] [Cited by in Crossref: 101] [Cited by in F6Publishing: 79] [Article Influence: 7.2] [Reference Citation Analysis]
148 Jeannot E, Pogribny IP, Beland FA, Rusyn I. Chronic administration of ethanol leads to an increased incidence of hepatocellular adenoma by promoting H-ras-mutated cells. Cancer Lett 2011;301:161-7. [PMID: 21168264 DOI: 10.1016/j.canlet.2010.11.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
149 Kashofer K, Tschernatsch MM, Mischinger HJ, Iberer F, Zatloukal K. The disease relevance of human hepatocellular xenograft models: molecular characterization and review of the literature. Cancer Lett 2009;286:121-8. [PMID: 19111389 DOI: 10.1016/j.canlet.2008.11.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
150 Thomeer MG, E Bröker ME, de Lussanet Q, Biermann K, Dwarkasing RS, de Man R, Ijzermans JN, de Vries M. Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings. Diagn Interv Radiol 2014;20:193-9. [PMID: 24509184 DOI: 10.5152/dir.2013.13315] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
151 Frulio N, Chiche L, Bioulac-Sage P, Balabaud C. Hepatocellular adenomatosis: what should the term stand for! Clin Res Hepatol Gastroenterol 2014;38:132-6. [PMID: 24126236 DOI: 10.1016/j.clinre.2013.08.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
152 Oldhafer KJ, Habbel V, Horling K, Makridis G, Wagner KC. Benign Liver Tumors. Visc Med 2020;36:292-303. [PMID: 33005655 DOI: 10.1159/000509145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
153 Lefkowitch JH. Neoplasms and Nodules. Scheuer's Liver Biopsy Interpretation. Elsevier; 2010. pp. 181-231. [DOI: 10.1016/b978-0-7020-3410-7.00017-4] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
154 Monga SP. β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis. Gastroenterology 2015;148:1294-310. [PMID: 25747274 DOI: 10.1053/j.gastro.2015.02.056] [Cited by in Crossref: 247] [Cited by in F6Publishing: 238] [Article Influence: 35.3] [Reference Citation Analysis]
155 Balabaud C, Laurent C, Le Bail B, Castain C, Possenti L, Frulio N, Chiche L, Blanc JF, Bioulac-Sage P. Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours. Liver Int 2018;38:1273-9. [PMID: 29265678 DOI: 10.1111/liv.13667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
156 Cannella R, Borhani AA, Minervini MI, Tsung A, Furlan A. Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images. Abdom Radiol44:1323-1330. [PMID: 30267107 DOI: 10.1007/s00261-018-1788-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
157 Kakar S, Ferrell LD. Glutamine synthetase staining and CTTNB1 mutation in hepatocellular adenomas: Correspondence. Hepatology 2017;66:2092-3. [DOI: 10.1002/hep.29567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
158 Cieply B, Zeng G, Proverbs-Singh T, Geller DA, Monga SP. Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. Hepatology 2009;49:821-31. [PMID: 19101982 DOI: 10.1002/hep.22695] [Cited by in Crossref: 109] [Cited by in F6Publishing: 98] [Article Influence: 8.4] [Reference Citation Analysis]
159 Paradis V. [How to classify a benign liver cell tumor in 2008?]. Gastroenterol Clin Biol 2008;32:294-5. [PMID: 18367360 DOI: 10.1016/j.gcb.2008.02.013] [Reference Citation Analysis]
160 Husainy MA, Sayyed F, Peddu P. Typical and atypical benign liver lesions: A review. Clin Imaging 2017;44:79-91. [PMID: 28486156 DOI: 10.1016/j.clinimag.2017.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
161 Bioulac-Sage P, Taouji S, Le Bail B, Possenti L, Balabaud C. Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens. Int J Hepatol. 2013;2013:417323. [PMID: 23509631 DOI: 10.1155/2013/417323] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
162 Margolskee E, Bao F, de Gonzalez AK, Moreira RK, Lagana S, Sireci AN, Sepulveda AR, Remotti H, Lefkowitch JH, Salomao M. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis. Diagn Pathol. 2016;11:27. [PMID: 26961851 DOI: 10.1186/s13000-016-0475-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
163 Sasaki M, Yoneda N, Kitamura S, Sato Y, Nakanuma Y. Characterization of hepatocellular adenoma based on the phenotypic classification: The Kanazawa experience. Hepatol Res. 2011;41:982-988. [PMID: 21883740 DOI: 10.1111/j.1872-034x.2011.00851.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
164 Hamaguchi K, Miyanishi K, Osuga T, Tanaka S, Ito R, Sakamoto H, Kubo T, Ohnuma H, Murase K, Takada K, Nagayama M, Kimura Y, Mizuguchi T, Takemasa I, Kato J. Association between Hepatic Oxidative Stress Related Factors and Activation of Wnt/β-Catenin Signaling in NAFLD-Induced Hepatocellular Carcinoma. Cancers 2022;14:2066. [DOI: 10.3390/cancers14092066] [Reference Citation Analysis]
165 Yasir S, Chen ZE, Jain D, Kakar S, Wu TT, Yeh MM, Torbenson MS. Hepatic Adenomas in Patients 60 and Older Are Enriched forHNF1AInactivation and Malignant Transformation. Am J Surg Pathol 2022. [PMID: 35383587 DOI: 10.1097/PAS.0000000000001892] [Reference Citation Analysis]
166 Balabaud C, Al-Rabih WR, Chen PJ, Evason K, Ferrell L, Hernandez-Prera JC, Huang SF, Longerich T, Park YN, Quaglia A. Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification. Int J Hepatol. 2013;2013:268625. [PMID: 23691331 DOI: 10.1155/2013/268625] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
167 Cannella R, Brancatelli G, Rangaswamy B, Minervini MI, Borhani AA, Furlan A. Enhancement pattern of hepatocellular adenoma (HCA) on MR imaging performed with Gd-EOB-DTPA versus other Gd-based contrast agents (GBCAs): An intraindividual comparison. Eur J Radiol 2019;119:108633. [PMID: 31437747 DOI: 10.1016/j.ejrad.2019.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
168 Calderaro J, Labrune P, Morcrette G, Rebouissou S, Franco D, Prévot S, Quaglia A, Bedossa P, Libbrecht L, Terracciano L. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. J Hepatol. 2013;58:350-357. [PMID: 23046672 DOI: 10.1016/j.jhep.2012.09.030] [Cited by in Crossref: 105] [Cited by in F6Publishing: 94] [Article Influence: 10.5] [Reference Citation Analysis]
169 Nault JC, Fabre M, Couchy G, Pilati C, Jeannot E, Tran Van Nhieu J, Saint-Paul MC, De Muret A, Redon MJ, Buffet C, Salenave S, Balabaud C, Prevot S, Labrune P, Bioulac-Sage P, Scoazec JY, Chanson P, Zucman-Rossi J. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol. 2012;56:184-191. [PMID: 21835143 DOI: 10.1016/j.jhep.2011.07.018] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 7.7] [Reference Citation Analysis]
170 Sasaki M, Ikeda T, Hatanaka KC, Nakanuma Y. Hyperplastic hepatocellular nodule with localized hemangiomatosis: A hither-to unrecognized type of hypervascular hepatic lesion. Hepatol Res. 2013;Epub ahead of print. [PMID: 23927680 DOI: 10.1111/hepr.12218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
171 van Malenstein H, van Pelt J, Verslype C. Molecular classification of hepatocellular carcinoma anno 2011. Eur J Cancer. 2011;47:1789-1797. [PMID: 21612914 DOI: 10.1016/j.ejca.2011.04.027] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
172 Kim H, Jang JJ, Kim DS, Yeom BW, Won NH. Clinicopathological analysis of hepatocellular adenoma according to new bordeaux classification: report of eight korean cases. Korean J Pathol 2013;47:411-7. [PMID: 24255628 DOI: 10.4132/KoreanJPathol.2013.47.5.411] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
173 Jiang K, Al-Diffhala S, Centeno BA. Primary Liver Cancers-Part 1: Histopathology, Differential Diagnoses, and Risk Stratification. Cancer Control. 2018;25:1073274817744625. [PMID: 29350068 DOI: 10.1177/1073274817744625] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
174 Thomeer MG, Willemssen FE, Biermann KK, El Addouli H, de Man RA, Ijzermans JN, Dwarkasing RS. MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents: Hepatobiliary MRI for Inflammatory Adenoma. J Magn Reson Imaging 2014;39:1259-64. [DOI: 10.1002/jmri.24281] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
175 Molares-Vila A, Corbalán-Rivas A, Carnero-Gregorio M, González-Cespón JL, Rodríguez-Cerdeira C. Biomarkers in Glycogen Storage Diseases: An Update. Int J Mol Sci 2021;22:4381. [PMID: 33922238 DOI: 10.3390/ijms22094381] [Reference Citation Analysis]
176 Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, Izard T, Balabaud C, Bioulac-Sage P, Zucman-Rossi J. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature. 2009;457:200-204. [PMID: 19020503 DOI: 10.1038/nature07475] [Cited by in Crossref: 354] [Cited by in F6Publishing: 316] [Article Influence: 25.3] [Reference Citation Analysis]
177 Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy. Nat Rev Endocrinol 2010;6:676-88. [PMID: 20975743 DOI: 10.1038/nrendo.2010.189] [Cited by in Crossref: 126] [Cited by in F6Publishing: 114] [Article Influence: 10.5] [Reference Citation Analysis]
178 Dourthe C, Julien C, Di Tommaso S, Dupuy JW, Dugot-Senant N, Brochard A, Le Bail B, Blanc JF, Chiche L, Balabaud C, Bioulac-Sage P, Saltel F, Raymond AA. Proteomic Profiling of Hepatocellular Adenomas Paves the Way to Diagnostic and Prognostic Approaches. Hepatology 2021. [PMID: 33754354 DOI: 10.1002/hep.31826] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
179 Herman P, Coelho FF, Perini MV, Lupinacci RM, D’Albuquerque LA, Cecconello I. Hepatocellular adenoma: an excellent indication for laparoscopic liver resection. HPB (Oxford). 2012;14:390-395. [PMID: 22568415 DOI: 10.1111/j.1477-2574.2012.00463.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
180 Lefkowitch JH. Recent developments in liver pathology. Human Pathology 2009;40:445-55. [DOI: 10.1016/j.humpath.2008.12.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
181 Frulio N, Balabaud C, Laurent C, Trillaud H, Bioulac-Sage P. Unclassified hepatocellular adenoma expressing ASS1 associated with inflammatory hepatocellular adenomas. Clin Res Hepatol Gastroenterol 2019;43:e63-7. [PMID: 31047837 DOI: 10.1016/j.clinre.2019.03.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
182 Bioulac-sage P, Lepreux S, Schledzewski K, Cubel G, Géraud C, Goerdt S, Balabaud C. Identification of liver sinusoidal endothelial cells in the human liver. Liver International 2010;30:773-6. [DOI: 10.1111/j.1478-3231.2010.02222.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
183 Asham EH, Kaseb A, Ghobrial RM. Management of Hepatocellular Carcinoma. Surgical Clinics of North America 2013;93:1423-50. [DOI: 10.1016/j.suc.2013.08.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
184 Verslype C, Libbrecht L. The diagnostic and therapeutic approach for primary solid liver tumours in adults. Best Practice & Research Clinical Gastroenterology 2007;21:983-96. [DOI: 10.1016/j.bpg.2007.09.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
185 Hardt A, Stippel D, Odenthal M, Hölscher AH, Dienes HP, Drebber U. Development of hepatocellular carcinoma associated with anabolic androgenic steroid abuse in a young bodybuilder: a case report. Case Rep Pathol. 2012;2012:195607. [PMID: 22934212 DOI: 10.1155/2012/195607] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
186 Joseph NM, Ferrell LD, Jain D, Torbenson MS, Wu TT, Yeh MM, Kakar S. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma. Mod Pathol 2014;27:62-72. [PMID: 23807780 DOI: 10.1038/modpathol.2013.114] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
187 Sanada Y, Mizuta K, Niki T, Tashiro M, Hirata Y, Okada N, Yamada N, Ihara Y, Urahashi T, Soejima Y, Fukusato T, Kondo F. Hepatocellular nodules resulting from congenital extrahepatic portosystemic shunts can differentiate into potentially malignant hepatocellular adenomas. J Hepatobiliary Pancreat Sci 2015;22:746-56. [DOI: 10.1002/jhbp.277] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
188 Kakar S, Chen X, Ho C, Burgart LJ, Adeyi O, Jain D, Sahai V, Ferrell LD. Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms. Histopathology. 2009;55:197-205. [PMID: 19694827 DOI: 10.1111/j.1365-2559.2009.03343.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
189 van Aalten SM, Thomeer MG, Terkivatan T, Dwarkasing RS, Verheij J, de Man RA, Ijzermans JN. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology. 2011;261:172-181. [PMID: 21875850 DOI: 10.1148/radiol.11110023] [Cited by in Crossref: 157] [Cited by in F6Publishing: 130] [Article Influence: 14.3] [Reference Citation Analysis]
190 Yoneda N, Matsui O, Kitao A, Kozaka K, Kobayashi S, Sasaki M, Yoshida K, Inoue D, Minami T, Gabata T. Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background. Radiographics 2016;36:2010-27. [PMID: 27740898 DOI: 10.1148/rg.2016160037] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 7.5] [Reference Citation Analysis]
191 Poussin K, Pilati C, Couchy G, Calderaro J, Bioulac-Sage P, Bacq Y, Paradis V, Leteurtre E, Sturm N, Ramos J. Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma. Oncoimmunology. 2013;2:e27090. [PMID: 24501689 DOI: 10.4161/onci.27090] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
192 Longerich T, Haller MT, Mogler C, Aulmann S, Lohmann V, Schirmacher P, Brand K. Annexin A2 as a differential diagnostic marker of hepatocellular tumors. Pathol Res Pract. 2011;207:8-14. [PMID: 20971570 DOI: 10.1016/j.prp.2010.09.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
193 Nault JC, Couchy G, Caruso S, Meunier L, Caruana L, Letouzé E, Rebouissou S, Paradis V, Calderaro J, Zucman-Rossi J. Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas. Hepatology 2018;68:964-76. [PMID: 29572896 DOI: 10.1002/hep.29884] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
194 Bise S, Frulio N, Hocquelet A, Alberti N, Blanc JF, Laurent C, Laumonier H, Balabaud C, Bioulac-Sage P, Trillaud H. New MRI features improve subtype classification of hepatocellular adenoma. Eur Radiol 2019;29:2436-47. [PMID: 30523457 DOI: 10.1007/s00330-018-5784-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
195 Paradis V. Hepatocellular Adenomas. Surgical Pathology Clinics 2013;6:311-31. [DOI: 10.1016/j.path.2013.03.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
196 Blanc JF, Frulio N, Chiche L, Sempoux C, Annet L, Hubert C, Gouw AS, de Jong KP, Bioulac-Sage P, Balabaud C. Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach. Clin Res Hepatol Gastroenterol 2015;39:180-7. [PMID: 25434466 DOI: 10.1016/j.clinre.2014.10.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
197 Sempoux C, Paradis V, Komuta M, Wee A, Calderaro J, Balabaud C, Quaglia A, Bioulac-sage P. Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders. Journal of Hepatology 2015;63:1173-80. [DOI: 10.1016/j.jhep.2015.06.017] [Cited by in Crossref: 55] [Cited by in F6Publishing: 42] [Article Influence: 7.9] [Reference Citation Analysis]
198 Laumonier H, Cailliez H, Balabaud C, Possenti L, Zucman-Rossi J, Bioulac-Sage P, Trillaud H. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings. AJR Am J Roentgenol. 2012;199:341-348. [PMID: 22826395 DOI: 10.2214/ajr.11.7046] [Cited by in Crossref: 44] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
199 Rodríguez-peláez M, Menéndez De Llano R, Varela M. Tumores benignos del hígado. Gastroenterología y Hepatología 2010;33:391-7. [DOI: 10.1016/j.gastrohep.2009.11.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
200 Goudard Y, Rouquie D, Bertocchi C, Daligand H, Baton O, Lahutte M, Terris B, Baranger B. [Malignant transformation of hepatocellular adenoma in men]. Gastroenterol Clin Biol 2010;34:168-70. [PMID: 20189337 DOI: 10.1016/j.gcb.2010.01.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
201 Hoenerhoff MJ, Pandiri AR, Lahousse SA, Hong HH, Ton TV, Masinde T, Auerbach SS, Gerrish K, Bushel PR, Shockley KR, Peddada SD, Sills RC. Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer. Toxicol Pathol 2011;39:678-99. [PMID: 21571946 DOI: 10.1177/0192623311407213] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
202 Koya Y, Suzuki T, Tai M, Ichii O, Matsuhashi N, Ejiri Y, Miyazawa M, Shibata M, Harada M, Kumabe T, Nakashima O. Inflammatory Hepatocellular Adenoma with Elevated Serum Protein Induced by Vitamin K Absence/Antagonist-II in Adult Males. Intern Med 2019;58:1739-46. [PMID: 30799343 DOI: 10.2169/internalmedicine.1958-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
203 Agostini CH, Ribeiro OD, Fernandes A, Caroli-bottino A, Pannain VL. Relevance of morphological features for hepatocellular adenoma classification in pathology practice. Surg Exp Pathol 2020;3. [DOI: 10.1186/s42047-020-00061-4] [Reference Citation Analysis]
204 Agnello F, Ronot M, Valla DC, Sinkus R, Van Beers BE, Vilgrain V. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. Radiology. 2012;262:511-519. [PMID: 22143926 DOI: 10.1148/radiol.11110922] [Cited by in Crossref: 63] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
205 Liu H, Zhao Q, Jin G, Qian Y, Gu Y, Dong H, Lu X, Cong W, Wu M. Unique genetic alterations and clinicopathological features of hepatocellular adenoma in Chinese population. Pathology - Research and Practice 2015;211:918-24. [DOI: 10.1016/j.prp.2015.09.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
206 Haas S, Merkelbach-Bruse S, Justenhoven C, Brauch H, Fischer HP. Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver. Pathol Res Pract. 2009;205:716-725. [PMID: 19596526 DOI: 10.1016/j.prp.2009.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
207 Liu TC, Vachharajani N, Chapman WC, Brunt EM. Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis. Mod Pathol 2014;27:420-32. [PMID: 24051694 DOI: 10.1038/modpathol.2013.148] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
208 Hadzic N, Finegold MJ. Liver neoplasia in children. Clin Liver Dis. 2011;15:443-462, vii-vix. [PMID: 21689623 DOI: 10.1016/j.cld.2011.03.011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
209 Szor DJ, Ursoline M, Herman P. Hepatic adenoma. Arq Bras Cir Dig 2013;26:219-22. [PMID: 24190381 DOI: 10.1590/s0102-67202013000300012] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
210 Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology. 2008;47:1955-1963. [PMID: 18433021 DOI: 10.1002/hep.22256] [Cited by in Crossref: 497] [Cited by in F6Publishing: 470] [Article Influence: 35.5] [Reference Citation Analysis]
211 Ahn SY, Park SY, Kweon YO, Tak WY, Bae HI, Cho SH. Successful treatment of multiple hepatocellular adenomas with percutaneous radiofrequency ablation. World J Gastroenterol 2013; 19(42): 7480-7486 [PMID: 24259982 DOI: 10.3748/wjg.v19.i42.7480] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
212 Yan Z, Grenert JP, Joseph NM, Ren C, Chen X, Shafizadeh N, Kakar S. Hepatic angiomyolipoma: mutation analysis and immunohistochemical pitfalls in diagnosis. Histopathology. 2018;73:101-108. [PMID: 29512829 DOI: 10.1111/his.13509] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
213 Bioulac-sage P, Balabaud C, Zucman-rossi J. Apport de l’immunohistochimie dans le diagnostic des tumeurs hépatocellulaires bénignes. Annales de Pathologie 2010;30:439-47. [DOI: 10.1016/j.annpat.2010.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
214 Glockner JF, Lee CU, Mounajjed T. Inflammatory hepatic adenomas: Characterization with hepatobiliary MRI contrast agents. Magn Reson Imaging 2018;47:103-10. [PMID: 29221964 DOI: 10.1016/j.mri.2017.12.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
215 Larson BK, Guindi M. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice. Am J Clin Pathol 2017;147:557-70. [PMID: 28472207 DOI: 10.1093/ajcp/aqx010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
216 Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Focal nodular hyperplasia, hepatocellular adenomas: past, present, future. Gastroenterol Clin Biol. 2010;34:355-358. [PMID: 20537479 DOI: 10.1016/j.gcb.2010.03.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
217 Ros PR, Goodman ZD. Genetics and imaging of hepatocellular adenomas: 2011 update. Invited commentary. Radiographics 2011;31:1543-5; discussion 1545. [PMID: 22103002 DOI: 10.1148/Radiographics.31.6.111543] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
218 Schirmacher P, Longerich T. Hochdifferenzierte Lebertumoren: Neue Entwicklungen und ihre diagnostische Relevanz. Pathologe 2009;30:200-6. [DOI: 10.1007/s00292-009-1214-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
219 Takahashi Y, Dungubat E, Kusano H, Ganbat D, Tomita Y, Odgerel S, Fukusato T. Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors. Int J Mol Sci 2021;22:5780. [PMID: 34071338 DOI: 10.3390/ijms22115780] [Reference Citation Analysis]
220 An SL, Wang LM, Rong WQ, Wu F, Sun W, Yu WB, Feng L, Liu FQ, Tian F, Wu JX. Hepatocellular adenoma with malignant transformation in male patients with non-cirrhotic livers. Chin J Cancer 2015;34:217-24. [PMID: 26058379 DOI: 10.1186/s40880-015-0014-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
221 Nault JC, Bioulac-Sage P, Zucman-Rossi J. Hepatocellular benign tumors-from molecular classification to personalized clinical care. Gastroenterology. 2013;144:888-902. [PMID: 23485860 DOI: 10.1053/j.gastro.2013.02.032] [Cited by in Crossref: 199] [Cited by in F6Publishing: 145] [Article Influence: 22.1] [Reference Citation Analysis]
222 Bioulac-Sage P, Sempoux C, Balabaud C. Hepatocellular adenoma: Classification, variants and clinical relevance. Semin Diagn Pathol. 2017;34:112-125. [PMID: 28131467 DOI: 10.1053/j.semdp.2016.12.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
223 Beaufrère A, Paradis V. Hepatocellular adenomas: review of pathological and molecular features. Hum Pathol 2021;112:128-37. [PMID: 33307077 DOI: 10.1016/j.humpath.2020.11.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
224 van Aalten SM, Verheij J, Terkivatan T, Dwarkasing RS, de Man RA, Ijzermans JN. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. J Hepatol. 2011;55:120-125. [PMID: 21145863 DOI: 10.1016/j.jhep.2010.10.030] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 6.2] [Reference Citation Analysis]
225 Zucman-rossi J, Amessou M, Bioulac-sage P, Rebouissou S. Identification de mutations activatrices de gp130 dans la tumorigenèse hépatique. Med Sci (Paris) 2008;24:1113-4. [DOI: 10.1051/medsci/200824121113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
226 Raggi F, Pissavino AL, Resaz R, Segalerba D, Puglisi A, Vanni C, Antonini F, Del Zotto G, Gamberucci A, Marcolongo P, Bosco MC, Grillo F, Mastracci L, Eva A. Development and characterization of an inducible mouse model for glycogen storage disease type Ib. J Inherit Metab Dis 2018;41:1015-25. [PMID: 29967951 DOI: 10.1007/s10545-018-0211-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
227 Kwon JE, Park YN. [Hepatic adenomatosis in glycogen storage disease]. Korean J Hepatol 2008;14:108-12. [PMID: 18367864 DOI: 10.3350/kjhep.2008.14.1.108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
228 Krause K, Tanabe KK. A Shifting Paradigm in Diagnosis and Management of Hepatic Adenoma. Ann Surg Oncol 2020;27:3330-8. [PMID: 32542565 DOI: 10.1245/s10434-020-08580-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
229 Jeannot E, Mellottee L, Bioulac-Sage P, Balabaud C, Scoazec JY, Tran Van Nhieu J, Bacq Y, Michalak S, Buob D, Laurent-Puig P, Rusyn I, Zucman-Rossi J; Groupe d'étude Génétique des Tumeurs Hépatiques (INSERM Network). Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes 2010;59:1836-44. [PMID: 20393147 DOI: 10.2337/db09-1819] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
230 Liao YT, Jeng YM, Lee YH, Tsai MK, Hu RH, Ho MC. The occurrence of primary hepatic adenoma in deceased donor renal transplant recipient. Int Braz J Urol 2014;40:118-22. [PMID: 24642158 DOI: 10.1590/S1677-5538.IBJU.2014.01.17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
231 Khanna M, Ramanathan S, Fasih N, Schieda N, Virmani V, McInnes MD. Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma. Insights Imaging. 2015;6:347-362. [PMID: 25790815 DOI: 10.1007/s13244-015-0399-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
232 Colle I, Laureys G, Raevens S, Libbrecht L, Leroy JG, Reyntjens K, Geerts A, Rogiers X, Troisi RI, Hoehn H, Schindler D, Hanenberg H, De Wilde V, Van Vlierberghe H. Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: A case report. Hepatol Res. 2013;43:991-998. [PMID: 23675868 DOI: 10.1111/hepr.12043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
233 Cannella R, Rangaswamy B, Minervini MI, Borhani AA, Tsung A, Furlan A. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia. AJR Am J Roentgenol 2019;212:538-46. [PMID: 30557050 DOI: 10.2214/AJR.18.20182] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
234 Choi WT, Kakar S. Immunohistochemistry in the Diagnosis of Hepatocellular Carcinoma. Gastroenterol Clin North Am. 2017;46:311-325. [PMID: 28506367 DOI: 10.1016/j.gtc.2017.01.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
235 Heim D, Gil-Ibanez I, Herden J, Parplys AC, Borgmann K, Schmidt-Arras D, Lohse AW, Rose-John S, Wege H. Constitutive gp130 activation rapidly accelerates the transformation of human hepatocytes via an impaired oxidative stress response. Oncotarget 2016;7:55639-48. [PMID: 27489351 DOI: 10.18632/oncotarget.10956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
236 Cristiano A, Dietrich A, Spina JC, Ardiles V, de Santibañes E. Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management. Updates Surg 2014;66:9-21. [DOI: 10.1007/s13304-013-0222-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
237 Raft MB, Jørgensen EN, Vainer B. Gene mutations in hepatocellular adenomas. Histopathology 2015;66:910-21. [PMID: 25195525 DOI: 10.1111/his.12539] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
238 Behari J. The Wnt/β-catenin signaling pathway in liver biology and disease. Expert Rev Gastroenterol Hepatol. 2010;4:745-756. [PMID: 21108594 DOI: 10.1586/egh.10.74] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 5.2] [Reference Citation Analysis]
239 Thomeer MG, Broker M, Verheij J, Doukas M, Terkivatan T, Bijdevaate D, De Man RA, Moelker A, IJzermans JN. Hepatocellular adenoma: when and how to treat? Update of current evidence. Therap Adv Gastroenterol. 2016;9:898-912. [PMID: 27803743 DOI: 10.1177/1756283x16663882] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
240 Schmidt-Arras D, Galun E, Rose-John S. The two facets of gp130 signalling in liver tumorigenesis. Semin Immunopathol 2021. [PMID: 34047814 DOI: 10.1007/s00281-021-00861-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
241 Shen XY, Hu XG, Kim YB, Kim MN, Hong SY, Kim BW, Wang HJ. Molecular classification of hepatocellular adenoma: A single-center experience. Ann Hepatobiliary Pancreat Surg 2019;23:109-14. [PMID: 31225410 DOI: 10.14701/ahbps.2019.23.2.109] [Reference Citation Analysis]
242 Ladam-Marcus V, Mac G, Job L, Piot-Veron S, Marcus C, Hoeffel C. [Contrast-enhanced ultrasound and liver imaging: review of the literature]. J Radiol 2009;90:93-106; quiz 107-8. [PMID: 19212278 DOI: 10.1016/s0221-0363(09)70087-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
243 Maylee H, Harada K, Igarashi S, Tohda G, Yamamoto M, Ren XS, Osawa T, Hasegawa Y, Takahashi N, Nakanuma Y. Case of telangiectatic/inflammatory hepatocellular adenoma arising in a patient with primary sclerosing cholangitis. Hepatol Res. 2012;42:611-618. [PMID: 22568458 DOI: 10.1111/j.1872-034X.2011.00962.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
244 Wang EY, Yeh SH, Tsai TF, Huang HP, Jeng YM, Lin WH, Chen WC, Yeh KH, Chen PJ, Chen DS. Depletion of β-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor development. Proc Natl Acad Sci U S A 2011;108:18384-9. [PMID: 22042854 DOI: 10.1073/pnas.1116386108] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
245 Bioulac-Sage P, Laumonier H, Rullier A, Cubel G, Laurent C, Zucman-Rossi J, Balabaud C. Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int. 2009;29:459-465. [PMID: 18803590 DOI: 10.1111/j.1478-3231.2008.01849.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 96] [Article Influence: 7.9] [Reference Citation Analysis]
246 Bioulac-sage P, Cubel G, Taouji S, Scoazec J, Leteurtre E, Paradis V, Sturm N, Van Nhieu JT, Wendum D, Bancel B, Ramos J, Paraf F, Saint Paul MC, Michalak S, Fabre M, Guettier C, Le Bail B, Zucman-rossi J, Balabaud C. Immunohistochemical Markers on Needle Biopsies Are Helpful for the Diagnosis of Focal Nodular Hyperplasia and Hepatocellular Adenoma Subtypes. American Journal of Surgical Pathology 2012;36:1691-9. [DOI: 10.1097/pas.0b013e3182653ece] [Cited by in Crossref: 89] [Cited by in F6Publishing: 25] [Article Influence: 8.9] [Reference Citation Analysis]
247 Sakellariou S, Morgan Y, Heaton N, Portmann B, Quaglia A, Tobal K. New monoallelic (partial tandem duplication) mutation of HNF1a gene in steatotic hepatocellular adenoma. Eur J Gastroenterol Hepatol 2011;23:623-7. [PMID: 21566527 DOI: 10.1097/MEG.0b013e328347964d] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
248 Mathew RP, Manolea F, Girgis S, Patel V, Low G. Malignant transformation of hepatic adenoma complicated by rupture and hemorrhage: An extremely rare clinical entity. Intractable Rare Dis Res 2019;8:266-70. [PMID: 31890454 DOI: 10.5582/irdr.2019.01089] [Reference Citation Analysis]
249 Sempoux C, Bisig B, Couchy G, Balabaud C, Zucman-Rossi J, Bioulac-Sage P. Malignant transformation of a β-catenin inflammatory adenoma due to an S45 β-catenin-activating mutation present 12 years before. Hum Pathol 2017;62:122-5. [PMID: 27984126 DOI: 10.1016/j.humpath.2016.10.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
250 Laumonier H, Rullier A, Saric J, Balabaud C, Bioulac-Sage P. Unexpected discovery of 2 cases of hepatocyte nuclear factor 1α-mutated infracentimetric adenomatosis. World J Gastroenterol 2008; 14(30): 4830-4833 [PMID: 18720549 DOI: 10.3748/wjg.14.4830] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
251 Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, Alavian SM, Lankarani KB, Farrokh P, Randel Nyengaard J. Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity. Eur J Histochem 2018;62:2859. [PMID: 29569872 DOI: 10.4081/ejh.2018.2859] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
252 Joseph NM, Umetsu SE, Shafizadeh N, Ferrell L, Kakar S. Genomic profiling of well-differentiated hepatocellular neoplasms with diffuse glutamine synthetase staining reveals similar genetics across the adenoma to carcinoma spectrum. Mod Pathol 2019;32:1627-36. [DOI: 10.1038/s41379-019-0282-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
253 Zucman-Rossi J. Molecular classification of hepatocellular carcinoma. Dig Liver Dis 2010;42 Suppl 3:S235-41. [PMID: 20547309 DOI: 10.1016/S1590-8658(10)60511-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
254 Inaba K, Sakaguchi T, Kurachi K, Mori H, Tao H, Nakamura T, Takehara Y, Baba S, Maekawa M, Sugimura H, Konno H. Hepatocellular adenoma associated with familial adenomatous polyposis coli. World J Hepatol 2012; 4(11): 322-326 [PMID: 23293720 DOI: 10.4254/wjh.v4.i11.322] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
255 Fukusato T, Soejima Y, Kondo F, Inoue M, Watanabe M, Takahashi Y, Aso T, Uozaki H, Sano K, Sanada Y, Niki T. Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β-catenin. Hepatol Res 2015;45:E32-42. [PMID: 25418671 DOI: 10.1111/hepr.12453] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
256 Denis de Senneville B, Frulio N, Laumonier H, Salut C, Lafitte L, Trillaud H. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns. Eur Radiol 2020;30:2995-3003. [PMID: 32002637 DOI: 10.1007/s00330-019-06566-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
257 Venkatesh SK, Hennedige T, Johnson GB, Hough DM, Fletcher JG. Imaging patterns and focal lesions in fatty liver: a pictorial review. Abdom Radiol (NY) 2017;42:1374-92. [PMID: 27999887 DOI: 10.1007/s00261-016-1002-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
258 Tekath M, Klotz T, Montoriol P, Joubert-zakeyh J, Garcier J, Da Ines D. Fat-containing lesions of the liver : A pictorial essay. Diagnostic and Interventional Imaging 2015;96:201-11. [DOI: 10.1016/j.diii.2013.11.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
259 Watkins J, Balabaud C, Bioulac-sage P, Sharma D, Dhillon A. Hepatocellular adenoma in advanced-stage fatty liver disease: . European Journal of Gastroenterology & Hepatology 2009;21:932-6. [DOI: 10.1097/meg.0b013e328311a67c] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
260 Gouw AS, Zeng W, Buiskool M, Platteel I, van den Heuvel MC, Poppema S, de Jong KP, Molema G. Molecular characterization of the vascular features of focal nodular hyperplasia and hepatocellular adenoma: a role for angiopoietin-1. Hepatology 2010;52:540-9. [PMID: 20683953 DOI: 10.1002/hep.23700] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
261 Chan ES, Yeh MM. The use of immunohistochemistry in liver tumors. Clin Liver Dis. 2010;14:687-703. [PMID: 21055690 DOI: 10.1016/j.cld.2010.10.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
262 Truant S, Boleslawski E, Duhamel A, Bouras AF, Louvet A, Febvay C, Leteurtre E, Huet G, Zerbib P, Dharancy S. Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection. Eur J Surg Oncol. 2012;38:1189-1196. [PMID: 22863304 DOI: 10.1016/j.ejso.2012.07.112] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
263 Longerich T, Schirmacher P. A new link between cancer and inflammation? Journal of Hepatology 2009;51:230-2. [DOI: 10.1016/j.jhep.2009.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
264 Saldarriaga J, Bisig B, Couchy G, Castain C, Zucman-Rossi J, Balabaud C, Sempoux C, Bioulac-Sage P. Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas. Histopathology 2017;71:989-93. [PMID: 28618047 DOI: 10.1111/his.13283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
265 El-ali AM, Davis JC, Cickelli JM, Squires JH. Contrast-enhanced ultrasound of liver lesions in children. Pediatr Radiol 2019;49:1422-32. [DOI: 10.1007/s00247-019-04361-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
266 Cappellen D, Catry-Thomas I, Castain C, Bioulac-Sage P. Hepatocellular adenoma with a double mutation HNF1A and IDH1 in a patient with Ollier disease. Liver Int 2021. [PMID: 34582629 DOI: 10.1111/liv.15066] [Reference Citation Analysis]
267 Shelmerdine SC, Roebuck DJ, Towbin AJ, McHugh K. MRI of paediatric liver tumours: How we review and report. Cancer Imaging 2016;16:21. [PMID: 27526937 DOI: 10.1186/s40644-016-0083-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
268 Piscaglia F, Lencioni R, Sagrini E, Pina CD, Cioni D, Vidili G, Bolondi L. Characterization of focal liver lesions with contrast-enhanced ultrasound. Ultrasound Med Biol. 2010;36:531-550. [PMID: 20350680 DOI: 10.1016/j.ultrasmedbio.2010.01.004] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 5.7] [Reference Citation Analysis]
269 Chan AWH, Yu S, Yu Y, Tong JHM, Wang L, Tin EKY, Chong CCN, Chan SL, Wong GLH, Wong VWS, Chan HLY, Lai PBS, To K. Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse. Histopathology 2016;69:971-84. [DOI: 10.1111/his.13029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
270 Larson BK, Dhall D, Guindi M. Immunohistochemistry as a surrogate for molecular diagnosis in hepatic tumours. Diagnostic Histopathology 2015;21:108-15. [DOI: 10.1016/j.mpdhp.2015.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
271 Isse K, Grama K, Abbott IM, Lesniak A, Lunz JG, Lee WM, Specht S, Corbitt N, Mizuguchi Y, Roysam B, Demetris AJ. Adding value to liver (and allograft) biopsy evaluation using a combination of multiplex quantum dot immunostaining, high-resolution whole-slide digital imaging, and automated image analysis. Clin Liver Dis 2010;14:669-85. [PMID: 21055689 DOI: 10.1016/j.cld.2010.07.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
272 Sanada Y, Mizuta K. Congenital absence of the portal vein: translated version. J Hepatobiliary Pancreat Sci 2018;25:359-69. [PMID: 30160060 DOI: 10.1002/jhbp.572] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
273 Kato K, Abe H, Hanawa N, Fukuzawa J, Matsuo R, Yonezawa T, Itoh S, Sato Y, Ika M, Shimizu S, Endo S, Hano H, Izu A, Sugitani M, Tsubota A. Hepatocellular adenoma in a woman who was undergoing testosterone treatment for gender identity disorder. Clin J Gastroenterol. 2018;11:401-410. [PMID: 29589251 DOI: 10.1007/s12328-018-0854-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
274 Resaz R, Rosa F, Grillo F, Basso L, Segalerba D, Puglisi A, Bosco MC, Mastracci L, Neumaier CE, Varesio L, Eva A. Characterization of high- and low-risk hepatocellular adenomas by magnetic resonance imaging in an animal model of glycogen storage disease type 1A. Dis Model Mech. 2019;12. [PMID: 30898969 DOI: 10.1242/dmm.038026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
275 Frau M, Simile MM, Tomasi ML, Demartis MI, Daino L, Seddaiu MA, Brozzetti S, Feo CF, Massarelli G, Solinas G, Feo F, Lee JS, Pascale RM. An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis. Cell Oncol (Dordr) 2012;35:163-73. [PMID: 22434528 DOI: 10.1007/s13402-011-0067-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
276 Paradis V, Bioulac-Sage P, Balabaud C. Congenital hepatic fibrosis with multiple HNF1α hepatocellular adenomas. Clin Res Hepatol Gastroenterol 2014;38:e115-6. [PMID: 24981780 DOI: 10.1016/j.clinre.2014.03.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
277 Liu D, Liu P, Cao L, Zhang Q, Chen Y. Screening the key genes of hepatocellular adenoma via microarray analysis of DNA expression and methylation profiles. Oncol Lett. 2017;14:3975-3980. [PMID: 28943905 DOI: 10.3892/ol.2017.6673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
278 Kakar S, Torbenson M, Jain D, Wu TT, Yeh M, Ferrell LD. Immunohistochemical pitfalls in the diagnosis of hepatocellular adenomas and focal nodular hyperplasia: accurate understanding of diverse staining patterns is essential for diagnosis and risk assessment. Mod Pathol 2015;28:159-60. [PMID: 25560413 DOI: 10.1038/modpathol.2014.121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
279 Longerich T, Breuhahn K, Schirmacher P. Molecular Pathology of Liver Tumors. In: Cheng L, Eble JN, editors. Molecular Surgical Pathology. New York: Springer; 2013. pp. 43-63. [DOI: 10.1007/978-1-4614-4900-3_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
280 Haddouche A, Bellanne-Chantelot C, Rod A, Fournier L, Chiche L, Gautier JF, Timsit J, Laboureau S, Chaillous L, Valero R, Larger E, Jeandidier N, Wilhelm JM, Popelier M, Guillausseau PJ, Thivolet C, Lecomte P, Benhamou PY, Reznik Y. Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series. J Diabetes 2020;12:48-57. [PMID: 31166087 DOI: 10.1111/1753-0407.12959] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
281 Barbier L, Nault J, Dujardin F, Scotto B, Besson M, de Muret A, Bourlier P, Zucman-rossi J, Salamé E, Bacq Y. Natural history of liver adenomatosis: A long-term observational study. Journal of Hepatology 2019;71:1184-92. [DOI: 10.1016/j.jhep.2019.08.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
282 Lo RC, Ng IO. Hepatocellular tumors: immunohistochemical analyses for classification and prognostication. Chin J Cancer Res. 2011;23:245-253. [PMID: 23359751 DOI: 10.1007/s11670-011-0245-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
283 Zarzour JG, Porter KK, Tchelepi H, Robbin ML. Contrast-enhanced ultrasound of benign liver lesions.Abdom Radiol (NY). 2018;43:848-860. [PMID: 29167944 DOI: 10.1007/s00261-017-1402-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
284 Fan Y, Fang X, Tajima A, Geng X, Ranganathan S, Dong H, Trucco M, Sperling MA. Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice. Front Endocrinol (Lausanne). 2014;5:218. [PMID: 25566190 DOI: 10.3389/fendo.2014.00218] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
285 Tsilimigras DI, Rahnemai-azar AA, Ntanasis-stathopoulos I, Gavriatopoulou M, Moris D, Spartalis E, Cloyd JM, Weber SM, Pawlik TM. Current Approaches in the Management of Hepatic Adenomas. J Gastrointest Surg 2019;23:199-209. [DOI: 10.1007/s11605-018-3917-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
286 Nault JC, Zucman Rossi J. Molecular classification of hepatocellular adenomas. Int J Hepatol. 2013;2013:315947. [PMID: 23401783 DOI: 10.1155/2013/315947] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
287 You J, Yang H, Lai Y, Simon L, Au J, Burkart AL. AT-rich interactive domain 2, p110α, p53, and β-catenin protein expression in hepatocellular carcinoma and clinicopathologic implications. Hum Pathol 2015;46:583-92. [PMID: 25701229 DOI: 10.1016/j.humpath.2015.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
288 Fujita N, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Kakihara D, Nakayama T, Morita K, Ishimatsu K, Honda H. Hyperintense Liver Masses at Hepatobiliary Phase Gadoxetic Acid–enhanced MRI: Imaging Appearances and Clinical Importance. RadioGraphics 2020;40:72-94. [DOI: 10.1148/rg.2020190037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
289 Putra J, Ferrell LD, Gouw ASH, Paradis V, Rishi A, Sempoux C, Balabaud C, Thung SN, Bioulac-Sage P. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon. Mod Pathol. 2020;33:665-675. [PMID: 31570768 DOI: 10.1038/s41379-019-0374-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
290 Bioulac-Sage P, Laumonier H, Sa Cunha A, Balabaud C. Hepatocellular adenomas. Liver Int. 2009;29:142. [PMID: 18828785 DOI: 10.1111/j.1478-3231.2008.01884.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
291 Shaked O, Siegelman ES, Olthoff K, Reddy KR. Biologic and Clinical Features of Benign Solid and Cystic Lesions of the Liver. Clinical Gastroenterology and Hepatology 2011;9:547-562.e4. [DOI: 10.1016/j.cgh.2011.03.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
292 Iida H, Osaki R, Matsubara A, Maehira H, Mori H, Fujimoto T, Andoh A, Kushima R, Nakashima O, Kondo F, Tani M. Two cases of benign hepatic nodules caused by sinusoidal dilatation with different hemodynamics. Clin J Gastroenterol 2020;13:873-81. [PMID: 32418022 DOI: 10.1007/s12328-020-01129-0] [Reference Citation Analysis]
293 Cassiman D, Libbrecht L, Verslype C, Meersseman W, Troisi R, Zucman-rossi J, Van Vlierberghe H. An adult male patient with multiple adenomas and a hepatocellular carcinoma: Mild Glycogen Storage Disease type Ia. Journal of Hepatology 2010;53:213-7. [DOI: 10.1016/j.jhep.2010.03.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
294 Nejak-Bowen KN, Thompson MD, Singh S, Bowen WC, Dar MJ, Khillan J, Dai C, Monga SP. Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin. Hepatology. 2010;51:1603-1613. [PMID: 20432254 DOI: 10.1002/hep.23538] [Cited by in Crossref: 106] [Cited by in F6Publishing: 106] [Article Influence: 8.8] [Reference Citation Analysis]
295 van Aalten SM, Witjes CD, de Man RA, Ijzermans JN, Terkivatan T. Can a decision-making model be justified in the management of hepatocellular adenoma? Liver Int. 2012;32:28-37. [PMID: 22098685 DOI: 10.1111/j.1478-3231.2011.02667.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
296 Castain C, Sempoux C, Brunt EM, Causse O, Heitzmann A, Hernandez-prera JC, Le Bail B, Schirmacher P, Thung SN, Balabaud C, Bioulac-sage P. Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association? Histopathology 2014;64:890-5. [DOI: 10.1111/his.12326] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
297 Denecke T, Steffen IG, Agarwal S, Seehofer D, Kröncke T, Hänninen EL, Kramme IB, Neuhaus P, Saini S, Hamm B. Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI. Eur Radiol. 2012;22:1769-1775. [PMID: 22437921 DOI: 10.1007/s00330-012-2422-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
298 Bioulac-sage P, Cubel G, Balabaud C. Pathological diagnosis of hepatocellular adenoma in clinical practice. Diagnostic Histopathology 2011;17:521-9. [DOI: 10.1016/j.mpdhp.2011.10.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
299 Müller-Peltzer K, Rübenthaler J, Negrao de Figueiredo G, Clevert DA. [CEUS-diagnosis of benign liver lesions]. Radiologe 2018;58:521-7. [PMID: 29704011 DOI: 10.1007/s00117-018-0390-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
300 van Aalten SM, Terkivatan T, van der Linden E, Verheij J, de Man RA, Ijzermans JN. Management of liver adenomatosis by radiofrequency ablation. Dig Surg 2011;28:173-7. [PMID: 21540605 DOI: 10.1159/000323746] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
301 Vernuccio F, Ronot M, Dioguardi Burgio M, Lebigot J, Allaham W, Aubé C, Brancatelli G, Vilgrain V. Uncommon evolutions and complications of common benign liver lesions. Abdom Radiol (NY) 2018;43:2075-96. [PMID: 29260281 DOI: 10.1007/s00261-017-1427-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
302 Walther Z, Jain D. Molecular pathology of hepatic neoplasms: classification and clinical significance. Patholog Res Int. 2011;2011:403929. [PMID: 21559202 DOI: 10.4061/2011/403929] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
303 Roux M, Pigneur F, Calderaro J, Baranes L, Chiaradia M, Tselikas L, Decaens T, Costentin C, Laurent A, Azoulay D, Mallat A, Zafrani ES, Rahmouni A, Luciani A. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI. J Magn Reson Imaging 2015;42:1249-58. [PMID: 25851028 DOI: 10.1002/jmri.24897] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
304 Sciarra A, Schmidt S, Pellegrinelli A, Maggioni M, Dondossola D, Pasquier J, Cigala C, Tosi D, Halkic N, Bulfamante G, Viale G, Bosari S, Balabaud C, Bioulac-Sage P, Sempoux C. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.Liver Int. 2019;39:158-167. [PMID: 30218633 DOI: 10.1111/liv.13964] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
305 van Rosmalen BV, Furumaya A, Klompenhouwer AJ, Tushuizen ME, Braat AE, Reinten RJ, Ligthart MAP, Haring MPD, de Meijer VE, van Voorthuizen T, Takkenberg RB, Dejong CHC, de Man RA, IJzermans JNM, Doukas M, van Gulik TM, Verheij J; Dutch Benign Liver Tumor Group and the PALGA group. Hepatocellular adenoma in men: A nationwide assessment of pathology and correlation with clinical course. Liver Int 2021. [PMID: 34155783 DOI: 10.1111/liv.14989] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
306 Nault JC, Zucman-Rossi J. TERT promoter mutations in primary liver tumors. Clin Res Hepatol Gastroenterol. 2016;40:9-14. [PMID: 26336998 DOI: 10.1016/j.clinre.2015.07.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 7.9] [Reference Citation Analysis]
307 Pilati C, Zucman-rossi J. Mutations leading to constitutive active gp130/JAK1/STAT3 pathway. Cytokine & Growth Factor Reviews 2015;26:499-506. [DOI: 10.1016/j.cytogfr.2015.07.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
308 Kishnani PS, Chuang TP, Bali D, Koeberl D, Austin S, Weinstein DA, Murphy E, Chen YT, Boyette K, Liu CH, Chen YT, Li LH. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease. Hum Mol Genet. 2009;18:4781-4790. [PMID: 19762333 DOI: 10.1093/hmg/ddp441] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
309 Agostini-vulaj D, Sharma AK, Findeis-hosey JJ, Mcmahon LA, Gonzalez RS. Distinction between inflammatory hepatocellular adenoma and mass effect on liver sampling. Human Pathology 2017;61:105-10. [DOI: 10.1016/j.humpath.2016.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
310 Graham RP, Terracciano LM, Meves A, Vanderboom PM, Dasari S, Yeh MM, Torbenson MS, Cruise MW. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss. Mod Pathol 2016;29:607-15. [DOI: 10.1038/modpathol.2016.59] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
311 Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun. 2013;4:2218. [PMID: 23887712 DOI: 10.1038/ncomms3218] [Cited by in Crossref: 362] [Cited by in F6Publishing: 352] [Article Influence: 45.3] [Reference Citation Analysis]
312 Chen YY, Yeh MM. Non-alcoholic fatty liver disease: A review with clinical and pathological correlation. J Formos Med Assoc 2021;120:68-77. [PMID: 32654868 DOI: 10.1016/j.jfma.2020.07.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
313 Di Tommaso L, Destro A, Seok JY, Balladore E, Terracciano L, Sangiovanni A, Iavarone M, Colombo M, Jang JJ, Yu E, Jin SY, Morenghi E, Park YN, Roncalli M. The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J Hepatol. 2009;50:746-754. [PMID: 19231003 DOI: 10.1016/j.jhep.2008.11.014] [Cited by in Crossref: 207] [Cited by in F6Publishing: 175] [Article Influence: 14.8] [Reference Citation Analysis]
314 Chang CY, Hernandez-Prera JC, Roayaie S, Schwartz M, Thung SN. Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol. 2013;2013:604860. [PMID: 23509632 DOI: 10.1155/2013/604860] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 6.2] [Reference Citation Analysis]
315 Cazorla A, Félix S, Valmary-Degano S, Sailley N, Thévenot T, Heyd B, Bioulac-Sage P. Polycystic ovary syndrome as a rare association with inflammatory hepatocellular adenoma: a case report. Clin Res Hepatol Gastroenterol 2014;38:e107-10. [PMID: 24994518 DOI: 10.1016/j.clinre.2014.05.005] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
316 Shanbhogue A, Shah SN, Zaheer A, Prasad SR, Takahashi N, Vikram R. Hepatocellular adenomas: current update on genetics, taxonomy, and management. J Comput Assist Tomogr. 2011;35:159-166. [PMID: 21412084 DOI: 10.1097/RCT.0b013e31820bad61] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
317 Glonnegger H, Schulze M, Kathemann S, Berg S, Füllgraf H, Tannapfel A, Gerner P, Grohmann J, Niemeyer C, Hettmer S. Case Report: Hepatic Adenoma in a Child With a Congenital Extrahepatic Portosystemic Shunt. Front Pediatr 2020;8:501. [PMID: 32984213 DOI: 10.3389/fped.2020.00501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
318 van den Esschert JW, Bieze M, Beuers UH, van Gulik TM, Bennink RJ. Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT. Eur J Nucl Med Mol Imaging. 2011;38:436-440. [PMID: 20717825 DOI: 10.1007/s00259-010-1584-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
319 Gupta S, Naini BV, Munoz R, Graham RP, Kipp BR, Torbenson MS, Mounajjed T. Hepatocellular Neoplasms Arising in Association With Androgen Use. Am J Surg Pathol 2016;40:454-61. [PMID: 26685086 DOI: 10.1097/PAS.0000000000000576] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
320 Amaddeo G, Cao Q, Ladeiro Y, Imbeaud S, Nault JC, Jaoui D, Gaston Mathe Y, Laurent C, Laurent A, Bioulac-Sage P, Calderaro J, Zucman-Rossi J. Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas. Gut. 2015;64:820-829. [PMID: 25021421 DOI: 10.1136/gutjnl-2013-306228] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 10.8] [Reference Citation Analysis]
321 Choi W, Kakar S. Atypical Hepatocellular Neoplasms: Review of Clinical, Morphologic, Immunohistochemical, Molecular, and Cytogenetic Features. Advances in Anatomic Pathology 2018;25:254-62. [DOI: 10.1097/pap.0000000000000189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
322 Fodor M, Primavesi F, Braunwarth E, Cardini B, Resch T, Bale R, Putzer D, Henninger B, Oberhuber R, Maglione M, Margreiter C, Schneeberger S, Öfner D, Stättner S. Indications for liver surgery in benign tumours. Eur Surg 2018;50:125-31. [PMID: 29875801 DOI: 10.1007/s10353-018-0536-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
323 Bioulac-sage P, Laumonier H, Balabaud CP. Benign Hepatocellular Tumors. Practical Hepatic Pathology: A Diagnostic Approach. Elsevier; 2011. pp. 473-88. [DOI: 10.1016/b978-0-443-06803-4.00034-4] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
324 Brunel T, Guibal A, Boularan C, Ducerf C, Mabrut JY, Bancel B, Boussel L, Rode A. Focal nodular hyperplasia and hepatocellular adenoma: The value of shear wave elastography for differential diagnosis. Eur J Radiol. 2015;84:2059-2064. [PMID: 26299323 DOI: 10.1016/j.ejrad.2015.07.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
325 Shin JH, Kim CJ, Jeon EJ, Sung CO, Shin HJ, Choi J, Yu E. Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas. J Pathol Transl Med. 2015;49:105-111. [PMID: 25812732 DOI: 10.4132/jptm.2015.01.19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
326 Izu A, Sugitani M, Kinukawa N, Matsumura H, Ogawa M, Moriyama M, Yamazaki S, Takayama T, Hano H, Yao T, Kanda H, Suzuki K, Hayashi S, Ariizumi S, Yamamoto M, Morishita Y, Matsumoto K, Nakamura N, Nakano M. Hepatocellular adenoma, approximately half and predominantly inflammatory subtype, in 38 Japanese patients with several differences in age, gender, and clinical background factors from Western populations. Hepatol Res 2021;51:336-42. [PMID: 33381872 DOI: 10.1111/hepr.13613] [Reference Citation Analysis]
327 McInnes MD, Hibbert RM, Inácio JR, Schieda N. Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review. Radiology 2015;277:413-23. [PMID: 26020440 DOI: 10.1148/radiol.2015142986] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 8.0] [Reference Citation Analysis]
328 Bioulac-Sage P, Sempoux C, Balabaud C. Hepatocellular Adenomas: Morphology and Genomics. Gastroenterol Clin North Am 2017;46:253-72. [PMID: 28506364 DOI: 10.1016/j.gtc.2017.01.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
329 Yiu WH, Pan CJ, Mead PA, Starost MF, Mansfield BC, Chou JY. Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice. J Hepatol. 2009;51:909-917. [PMID: 19376605 DOI: 10.1016/j.jhep.2008.11.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
330 Longerich T, Endris V, Neumann O, Rempel E, Kirchner M, Abadi Z, Uhrig S, Kriegsmann M, Weiss KH, Breuhahn K, Mehrabi A, Weber TF, Wilkens L, Straub BK, Rosenwald A, Schulze F, Brors B, Froehling S, Pellegrino R, Budczies J, Schirmacher P, Stenzinger A. RSPO2 gene rearrangement: a powerful driver of β-catenin activation in liver tumours. Gut 2019;68:1287-96. [PMID: 30901310 DOI: 10.1136/gutjnl-2018-317632] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
331 Sumiyoshi T, Moriguchi M, Kanemoto H, Asakura K, Sasaki K, Sugiura T, Mizuno T, Uesaka K. Liver-specific contrast agent-enhanced magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case. Surg Today. 2012;42:200-204. [PMID: 22160355 DOI: 10.1007/s00595-011-0067-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
332 Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, Belghiti J. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009;137:1698-1705. [PMID: 19664629 DOI: 10.1053/j.gastro.2009.07.061] [Cited by in Crossref: 266] [Cited by in F6Publishing: 199] [Article Influence: 20.5] [Reference Citation Analysis]
333 Eguchi A, Hasegawa H, Iwasa M, Tamai Y, Ohata K, Oikawa T, Sugaya T, Takei Y. Serum Liver-Type Fatty Acid-Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma. Hepatol Commun. 2019;3:825-837. [PMID: 31168516 DOI: 10.1002/hep4.1350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
334 Costa AF, Clarke SE, Stueck AE, McInnes MDF, Thipphavong S. Benign Neoplasms, Mass-Like Infections, and Pseudotumors That Mimic Hepatic Malignancy at MRI. J Magn Reson Imaging 2021;53:979-94. [PMID: 32621572 DOI: 10.1002/jmri.27251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
335 Nault JC, Couchy G, Balabaud C, Morcrette G, Caruso S, Blanc JF, Bacq Y, Calderaro J, Paradis V, Ramos J, Scoazec JY, Gnemmi V, Sturm N, Guettier C, Fabre M, Savier E, Chiche L, Labrune P, Selves J, Wendum D, Pilati C, Laurent A, De Muret A, Le Bail B, Rebouissou S, Imbeaud S, Bioulac-Sage P, Letouzé E, Zucman-Rossi J; GENTHEP Investigators. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation. Gastroenterology 2017;152:880-894.e6. [PMID: 27939373 DOI: 10.1053/j.gastro.2016.11.042] [Cited by in Crossref: 168] [Cited by in F6Publishing: 144] [Article Influence: 28.0] [Reference Citation Analysis]
336 Kakar S, Grenert JP, Paradis V, Pote N, Jakate S, Ferrell LD. Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor. Mod Pathol. 2014;27:1499-1509. [PMID: 24743216 DOI: 10.1038/modpathol.2014.50] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
337 Thomas AJ, Menias CO, Pickhardt PJ, Shaaban AM, Gaballah AH, Yedururi S, Elsayes KM. Bleeding Liver Masses: Imaging Features With Pathologic Correlation and Impact on Management. AJR Am J Roentgenol 2019;213:8-16. [PMID: 30973778 DOI: 10.2214/AJR.19.21240] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
338 Goltz D, Fischer HP. Current Proceedings in the Molecular Dissection of Hepatocellular Adenomas: Review and Hands-on Guide for Diagnosis. Int J Mol Sci 2015;16:20994-1007. [PMID: 26404250 DOI: 10.3390/ijms160920994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
339 Goodman ZD, Terracciano LM, Wee A. Tumours and tumour-like lesions of the liver. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 761-851. [DOI: 10.1016/b978-0-7020-3398-8.00014-3] [Cited by in Crossref: 21] [Article Influence: 2.1] [Reference Citation Analysis]
340 Pilati C, Amessou M, Bihl MP, Balabaud C, Nhieu JT, Paradis V, Nault JC, Izard T, Bioulac-Sage P, Couchy G, Poussin K, Zucman-Rossi J. Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med. 2011;208:1359-1366. [PMID: 21690253 DOI: 10.1084/jem.20110283] [Cited by in Crossref: 176] [Cited by in F6Publishing: 166] [Article Influence: 16.0] [Reference Citation Analysis]
341 Reis H, Padden J, Ahrens M, Pütter C, Bertram S, Pott LL, Reis AC, Weber F, Juntermanns B, Hoffmann AC, Eisenacher M, Schlaak JF, Canbay A, Meyer HE, Sitek B, Baba HA. Differential proteomic and tissue expression analyses identify valuable diagnostic biomarkers of hepatocellular differentiation and hepatoid adenocarcinomas. Pathology 2015;47:543-50. [PMID: 26308133 DOI: 10.1097/PAT.0000000000000298] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
342 Cieply B, Zeng G, Proverbs-Singh T, Geller DA, Monga SP. Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. Hepatology 2009;49:821-31. [PMID: 19101982 DOI: 10.1002/hep.22695] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
343 Frulio N, Laumonier H, Balabaud C, Trillaud H, Bioulac-Sage P. Hepatic congestion plays a role in liver stiffness. Hepatology. 2009;50:1674-1675. [PMID: 19670411 DOI: 10.1002/hep.23109] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
344 Deniz K, Umetsu SE, Ferrell L, Yılmaz F, Güllüoğlu M, Sağol Ö, Doğusoy GB, Kırımlıoğlu H, Turhan N, Doran F, Kepil N, Çelikel ÇA, Nart D, Özgüven BY, Ceyran B, Karadağ N, Kır G, Erden E, Yılmaz G, Akyol G. Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria. Histopathology 2021;79:23-33. [PMID: 33406290 DOI: 10.1111/his.14330] [Reference Citation Analysis]
345 Ozaki K, Harada K, Yamamoto T, Aoyagi H, Kaizaki Y, Yoshikawa J. Unclassified hepatocellular adenoma in a middle-aged woman with glucose intolerance. Clin J Gastroenterol 2018;11:75-82. [PMID: 29116626 DOI: 10.1007/s12328-017-0788-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
346 Ling C, Khalid S, Martin D, Hanson J, Castresana D, McCarthy D. HCCs and HCAs in Non-cirrhotic Patients: What You See May Not Be Enough. Dig Dis Sci 2019;64:3440-5. [PMID: 31673903 DOI: 10.1007/s10620-019-05920-z] [Reference Citation Analysis]
347 Pugmire BS, Towbin AJ. Magnetic resonance imaging of primary pediatric liver tumors. Pediatr Radiol 2016;46:764-77. [PMID: 27229495 DOI: 10.1007/s00247-016-3612-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
348 Védie AL, Sutter O, Ziol M, Nault JC. Molecular classification of hepatocellular adenomas: impact on clinical practice. Hepat Oncol 2018;5:HEP04. [PMID: 30302195 DOI: 10.2217/hep-2017-0023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
349 Pérez Rojas J, Guarín Corredor MJ, Artes Martinez MJ, Vera Sempere FJ, Brisa Estelles C, Huart Peris MC, Hernandez Giron S. [Immunophenotypic classification of 3 cases of hepatocellular adenoma. Differential diagnosis with focal nodular hyperplasia]. Gastroenterol Hepatol 2013;36:388-95. [PMID: 23664829 DOI: 10.1016/j.gastrohep.2013.02.013] [Reference Citation Analysis]
350 Thapar M, Grapp O, Fisher C. Management of hepatic adenomatosis. Curr Gastroenterol Rep 2015;17:12. [PMID: 25740249 DOI: 10.1007/s11894-015-0434-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
351 Sempoux C, Gouw ASH, Dunet V, Paradis V, Balabaud C, Bioulac-Sage P. Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-mutated Hepatocellular Adenomas. Am J Surg Pathol 2021;45:477-87. [PMID: 33560657 DOI: 10.1097/PAS.0000000000001675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
352 Ahmad I, Iyer A, Marginean CE, Yeh MM, Ferrell L, Qin L, Bifulco CB, Jain D. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma. Hum Pathol. 2009;40:726-734. [PMID: 19157505 DOI: 10.1016/j.humpath.2008.10.018] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
353 Larson BK, Guindi M. Applying criteria for hepatocellular neoplasm of uncertain malignant potential reclassifies more than half of hepatocellular adenomas. Ann Diagn Pathol 2021;55:151833. [PMID: 34597957 DOI: 10.1016/j.anndiagpath.2021.151833] [Reference Citation Analysis]
354 Nault JC, Paradis V, Cherqui D, Vilgrain V, Zucman-Rossi J. Molecular classification of hepatocellular adenoma in clinical practice. J Hepatol. 2017;67:1074-1083. [PMID: 28733222 DOI: 10.1016/j.jhep.2017.07.009] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 14.2] [Reference Citation Analysis]
355 Bayard Q, Caruso S, Couchy G, Rebouissou S, Bioulac Sage P, Balabaud C, Paradis V, Sturm N, de Muret A, Guettier C, Bonsang B, Copie C, Letouzé E, Calderaro J, Imbeaud S, Nault JC, Zucman-Rossi J. Recurrent chromosomal rearrangements of ROS1, FRK and IL6 activating JAK/STAT pathway in inflammatory hepatocellular adenomas. Gut 2020;69:1667-76. [PMID: 31907296 DOI: 10.1136/gutjnl-2019-319790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
356 DiPaola F, Trout AT, Walther AE, Gupta A, Sheridan R, Campbell KM, Tiao G, Bezerra JA, Bove KE, Patel M, Nathan JD. Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes. Dig Dis Sci 2020;65:1239-51. [PMID: 31549332 DOI: 10.1007/s10620-019-05834-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
357 Torbenson M. Hepatic Adenomas. Surgical Pathology Clinics 2018;11:351-66. [DOI: 10.1016/j.path.2018.02.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]